[
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0001",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 6.14,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-04-15",
    "ADT": "2020-10-19",
    "ADY": 188,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0001",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 14.21,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-04-15",
    "ADT": "2021-06-22",
    "ADY": 434,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0002",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 16.74,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-06-10",
    "ADT": "2021-11-02",
    "ADY": 511,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0002",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 17.78,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-06-10",
    "ADT": "2021-12-03",
    "ADY": 542,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0003",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 20.34,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-01-20",
    "ADT": "2023-10-01",
    "ADY": 620,
    "AGE": 48,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0003",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 15.81,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2022-01-20",
    "ADT": "2023-05-16",
    "ADY": 482,
    "AGE": 48,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0004",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 7.82,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-09-17",
    "ADT": "2022-05-13",
    "ADY": 239,
    "AGE": 78,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0004",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 5.77,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-09-17",
    "ADT": "2022-03-12",
    "ADY": 177,
    "AGE": 78,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0005",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 13.04,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-12-25",
    "ADT": "2022-01-26",
    "ADY": 398,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0005",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.31,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-12-25",
    "ADT": "2021-08-05",
    "ADY": 224,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0006",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 12.23,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2022-02-12",
    "ADT": "2023-02-19",
    "ADY": 373,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0006",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 0.3,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2022-02-12",
    "ADT": "2022-02-21",
    "ADY": 10,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0007",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 12.18,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-07-24",
    "ADT": "2021-07-30",
    "ADY": 372,
    "AGE": 70,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0007",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 0.79,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-07-24",
    "ADT": "2020-08-17",
    "ADY": 25,
    "AGE": 70,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0008",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 20.7,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-01-12",
    "ADT": "2023-10-04",
    "ADY": 631,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0008",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 20.7,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-01-12",
    "ADT": "2023-10-04",
    "ADY": 631,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0009",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 26.97,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-07-04",
    "ADT": "2023-10-03",
    "ADY": 822,
    "AGE": 70,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0009",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 26.97,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-07-04",
    "ADT": "2023-10-03",
    "ADY": 822,
    "AGE": 70,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0010",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 20.39,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-05-14",
    "ADT": "2023-01-25",
    "ADY": 622,
    "AGE": 79,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0010",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 19.27,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-05-14",
    "ADT": "2022-12-22",
    "ADY": 588,
    "AGE": 79,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0011",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 28.75,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-05-12",
    "ADT": "2023-10-04",
    "ADY": 876,
    "AGE": 44,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0011",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.28,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-05-12",
    "ADT": "2021-12-20",
    "ADY": 223,
    "AGE": 44,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0012",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 22.08,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-12-04",
    "ADT": "2023-10-07",
    "ADY": 673,
    "AGE": 51,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0012",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 22.08,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-12-04",
    "ADT": "2023-10-07",
    "ADY": 673,
    "AGE": 51,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0013",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 32.46,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-01-18",
    "ADT": "2023-10-03",
    "ADY": 989,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0013",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 28.95,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-01-18",
    "ADT": "2023-06-18",
    "ADY": 882,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0014",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 8.35,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-03-26",
    "ADT": "2020-12-05",
    "ADY": 255,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0014",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.54,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-03-26",
    "ADT": "2020-08-11",
    "ADY": 139,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0015",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 22.19,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-04-09",
    "ADT": "2023-02-13",
    "ADY": 676,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0015",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 29.76,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-04-09",
    "ADT": "2023-10-02",
    "ADY": 907,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0016",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 8.29,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-09-30",
    "ADT": "2022-06-09",
    "ADY": 253,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0016",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.98,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-09-30",
    "ADT": "2022-05-31",
    "ADY": 244,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0017",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 26.13,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-03-07",
    "ADT": "2022-05-11",
    "ADY": 796,
    "AGE": 52,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0017",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 10.73,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-03-07",
    "ADT": "2021-01-28",
    "ADY": 328,
    "AGE": 52,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0018",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 16.62,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-12-26",
    "ADT": "2023-05-16",
    "ADY": 507,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0018",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 3.88,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-12-26",
    "ADT": "2022-04-23",
    "ADY": 119,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0019",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 21.23,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-04-17",
    "ADT": "2022-01-23",
    "ADY": 647,
    "AGE": 80,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0019",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.69,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-04-17",
    "ADT": "2020-09-07",
    "ADY": 144,
    "AGE": 80,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0020",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 10.62,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-06-18",
    "ADT": "2022-05-07",
    "ADY": 324,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0020",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 1.08,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-06-18",
    "ADT": "2021-07-21",
    "ADY": 34,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0021",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 2.78,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-04-18",
    "ADT": "2021-07-12",
    "ADY": 86,
    "AGE": 71,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0021",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 1.29,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-04-18",
    "ADT": "2021-05-27",
    "ADY": 40,
    "AGE": 71,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0022",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 14.65,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-02-06",
    "ADT": "2022-04-28",
    "ADY": 447,
    "AGE": 78,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0022",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 5.27,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-02-06",
    "ADT": "2021-07-16",
    "ADY": 161,
    "AGE": 78,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0023",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 19.09,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-03-01",
    "ADT": "2023-10-03",
    "ADY": 582,
    "AGE": 87,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0023",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 19.09,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-03-01",
    "ADT": "2023-10-03",
    "ADY": 582,
    "AGE": 87,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0024",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 40.6,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-05-18",
    "ADT": "2023-10-06",
    "ADY": 1237,
    "AGE": 71,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0024",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 14.25,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-05-18",
    "ADT": "2021-07-26",
    "ADY": 435,
    "AGE": 71,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0025",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 11.25,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-07-02",
    "ADT": "2022-06-09",
    "ADY": 343,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0001-0025",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 0.99,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-07-02",
    "ADT": "2021-08-01",
    "ADY": 31,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0001",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 29.86,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-04-11",
    "ADT": "2023-10-07",
    "ADY": 910,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0001",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 29.86,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-04-11",
    "ADT": "2023-10-07",
    "ADY": 910,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0002",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 20.37,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-01-22",
    "ADT": "2023-10-04",
    "ADY": 621,
    "AGE": 49,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0002",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 20.37,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-01-22",
    "ADT": "2023-10-04",
    "ADY": 621,
    "AGE": 49,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0003",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.02,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-10-05",
    "ADT": "2021-05-07",
    "ADY": 215,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0003",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 9.43,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-10-05",
    "ADT": "2021-07-19",
    "ADY": 288,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0004",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 39.68,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-06-13",
    "ADT": "2023-10-04",
    "ADY": 1209,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0004",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 16.41,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-06-13",
    "ADT": "2021-10-26",
    "ADY": 501,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0005",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 24.14,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-07-27",
    "ADT": "2023-08-01",
    "ADY": 736,
    "AGE": 50,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0005",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.11,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-07-27",
    "ADT": "2021-11-29",
    "ADY": 126,
    "AGE": 50,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0006",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 25.85,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-08-11",
    "ADT": "2023-10-07",
    "ADY": 788,
    "AGE": 80,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0006",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 21.56,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-08-11",
    "ADT": "2023-05-29",
    "ADY": 657,
    "AGE": 80,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0007",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 24.07,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-02-06",
    "ADT": "2023-02-09",
    "ADY": 734,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0007",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 15.99,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-02-06",
    "ADT": "2022-06-08",
    "ADY": 488,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0008",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 20.07,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-01-30",
    "ADT": "2023-10-03",
    "ADY": 612,
    "AGE": 75,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0008",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 20.07,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-01-30",
    "ADT": "2023-10-03",
    "ADY": 612,
    "AGE": 75,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0009",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 21.29,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-12-27",
    "ADT": "2023-10-06",
    "ADY": 649,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0009",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 21.29,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-12-27",
    "ADT": "2023-10-06",
    "ADY": 649,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0010",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 21.81,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-05-11",
    "ADT": "2022-03-06",
    "ADY": 665,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0010",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.01,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-05-11",
    "ADT": "2020-12-10",
    "ADY": 214,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0011",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 4.86,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-04-09",
    "ADT": "2020-09-04",
    "ADY": 149,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0011",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 3.8,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-04-09",
    "ADT": "2020-08-03",
    "ADY": 117,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0012",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 40.47,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-05-21",
    "ADT": "2023-10-05",
    "ADY": 1233,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0012",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.37,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-05-21",
    "ADT": "2020-08-01",
    "ADY": 73,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0013",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 25.33,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-08-27",
    "ADT": "2023-10-07",
    "ADY": 772,
    "AGE": 74,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0013",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 8.09,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-08-27",
    "ADT": "2022-04-30",
    "ADY": 247,
    "AGE": 74,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0014",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 11.96,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-04-22",
    "ADT": "2022-04-21",
    "ADY": 365,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0014",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.79,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-04-22",
    "ADT": "2021-12-15",
    "ADY": 238,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0015",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 10.5,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-02-22",
    "ADT": "2022-01-08",
    "ADY": 321,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0015",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 8.22,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-02-22",
    "ADT": "2021-10-30",
    "ADY": 251,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0016",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 0.41,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-09-11",
    "ADT": "2020-09-23",
    "ADY": 13,
    "AGE": 77,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0016",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 4.22,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-09-11",
    "ADT": "2021-01-17",
    "ADY": 129,
    "AGE": 77,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0017",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 0.96,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-04-15",
    "ADT": "2020-05-14",
    "ADY": 30,
    "AGE": 77,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0017",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 41.66,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-04-15",
    "ADT": "2023-10-05",
    "ADY": 1269,
    "AGE": 77,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0018",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 28.22,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-05-30",
    "ADT": "2023-10-06",
    "ADY": 860,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0018",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.06,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-05-30",
    "ADT": "2021-12-31",
    "ADY": 216,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0019",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 20.04,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-02-01",
    "ADT": "2023-10-04",
    "ADY": 611,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0019",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 20.04,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-02-01",
    "ADT": "2023-10-04",
    "ADY": 611,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0020",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 36.77,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-03-28",
    "ADT": "2023-04-21",
    "ADY": 1120,
    "AGE": 78,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0020",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 9.83,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-03-28",
    "ADT": "2021-01-21",
    "ADY": 300,
    "AGE": 78,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0021",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 33.94,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-12-02",
    "ADT": "2023-10-01",
    "ADY": 1034,
    "AGE": 76,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0021",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 33.15,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-12-02",
    "ADT": "2023-09-07",
    "ADY": 1010,
    "AGE": 76,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0022",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 26.71,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-05-27",
    "ADT": "2022-08-18",
    "ADY": 814,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0022",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 21.45,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-05-27",
    "ADT": "2022-03-11",
    "ADY": 654,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0023",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 20.55,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-10-19",
    "ADT": "2022-07-07",
    "ADY": 627,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0023",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 12.06,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-10-19",
    "ADT": "2021-10-21",
    "ADY": 368,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0024",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 15.53,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-11-18",
    "ADT": "2022-03-06",
    "ADY": 474,
    "AGE": 75,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0024",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 12.22,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-11-18",
    "ADT": "2021-11-25",
    "ADY": 373,
    "AGE": 75,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0025",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 41,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-05-04",
    "ADT": "2023-10-04",
    "ADY": 1249,
    "AGE": 51,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0002-0025",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 41,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-05-04",
    "ADT": "2023-10-04",
    "ADY": 1249,
    "AGE": 51,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0001",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 6.06,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-08-13",
    "ADT": "2022-02-13",
    "ADY": 185,
    "AGE": 41,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0001",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 0.21,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-08-13",
    "ADT": "2021-08-19",
    "ADY": 7,
    "AGE": 41,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0002",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 4.42,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-12-19",
    "ADT": "2021-05-03",
    "ADY": 136,
    "AGE": 81,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0002",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 1.66,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-12-19",
    "ADT": "2021-02-08",
    "ADY": 52,
    "AGE": 81,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0003",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 19.81,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-02-10",
    "ADT": "2023-10-06",
    "ADY": 604,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0003",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 19.81,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-02-10",
    "ADT": "2023-10-06",
    "ADY": 604,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0004",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 25.69,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-08-12",
    "ADT": "2023-10-03",
    "ADY": 783,
    "AGE": 79,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0004",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.29,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-08-12",
    "ADT": "2022-03-22",
    "ADY": 223,
    "AGE": 79,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0005",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.91,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-05-08",
    "ADT": "2021-08-05",
    "ADY": 90,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0005",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 12.58,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-05-08",
    "ADT": "2022-05-26",
    "ADY": 384,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0006",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 40.97,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-05-06",
    "ADT": "2023-10-05",
    "ADY": 1248,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0006",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 34.37,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-05-06",
    "ADT": "2023-03-18",
    "ADY": 1047,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0007",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 27.51,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-05-28",
    "ADT": "2022-09-12",
    "ADY": 838,
    "AGE": 47,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0007",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 14.88,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-05-28",
    "ADT": "2021-08-24",
    "ADY": 454,
    "AGE": 47,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0008",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 40.48,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-04-09",
    "ADT": "2023-08-24",
    "ADY": 1233,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0008",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 24.69,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-04-09",
    "ADT": "2022-05-01",
    "ADY": 753,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0009",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 21.45,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-12-18",
    "ADT": "2023-10-02",
    "ADY": 654,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0009",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 21.45,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-12-18",
    "ADT": "2023-10-02",
    "ADY": 654,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0010",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 19.97,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-02-01",
    "ADT": "2023-10-02",
    "ADY": 609,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0010",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 19.97,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-02-01",
    "ADT": "2023-10-02",
    "ADY": 609,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0011",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 28.29,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-05-29",
    "ADT": "2023-10-07",
    "ADY": 862,
    "AGE": 74,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0011",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 28.29,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-05-29",
    "ADT": "2023-10-07",
    "ADY": 862,
    "AGE": 74,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0012",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 6.37,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-10-15",
    "ADT": "2021-04-27",
    "ADY": 195,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0012",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 1.96,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-10-15",
    "ADT": "2020-12-14",
    "ADY": 61,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0013",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 30.32,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-03-24",
    "ADT": "2023-10-03",
    "ADY": 924,
    "AGE": 74,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0013",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 6.54,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-03-24",
    "ADT": "2021-10-09",
    "ADY": 200,
    "AGE": 74,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0014",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 8.66,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-11-22",
    "ADT": "2021-08-13",
    "ADY": 265,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0014",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.71,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-11-22",
    "ADT": "2021-07-15",
    "ADY": 236,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0015",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 30.19,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-04-01",
    "ADT": "2023-10-07",
    "ADY": 920,
    "AGE": 54,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0015",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 30.19,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-04-01",
    "ADT": "2023-10-07",
    "ADY": 920,
    "AGE": 54,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0016",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 11.23,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-05-05",
    "ADT": "2022-04-12",
    "ADY": 343,
    "AGE": 81,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0016",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 1.4,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-05-05",
    "ADT": "2021-06-17",
    "ADY": 44,
    "AGE": 81,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0017",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 28.98,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-05-04",
    "ADT": "2023-10-03",
    "ADY": 883,
    "AGE": 85,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0017",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 6.88,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-05-04",
    "ADT": "2021-11-29",
    "ADY": 210,
    "AGE": 85,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0018",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 5.1,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-03-17",
    "ADT": "2020-08-19",
    "ADY": 156,
    "AGE": 85,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0018",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 20.15,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-03-17",
    "ADT": "2021-11-20",
    "ADY": 614,
    "AGE": 85,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0019",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 29.6,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-04-18",
    "ADT": "2023-10-06",
    "ADY": 902,
    "AGE": 84,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0019",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 13.93,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-04-18",
    "ADT": "2022-06-16",
    "ADY": 425,
    "AGE": 84,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0020",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 25.39,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-08-25",
    "ADT": "2023-10-07",
    "ADY": 774,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0020",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 17.87,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-08-25",
    "ADT": "2023-02-20",
    "ADY": 545,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0021",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 39.19,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-06-30",
    "ADT": "2023-10-06",
    "ADY": 1194,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0021",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 28.69,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-06-30",
    "ADT": "2022-11-20",
    "ADY": 874,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0022",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 13.95,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-07-29",
    "ADT": "2022-09-27",
    "ADY": 426,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0022",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 10.71,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-07-29",
    "ADT": "2022-06-20",
    "ADY": 327,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0023",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 35.78,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-10-09",
    "ADT": "2023-10-03",
    "ADY": 1090,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0023",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 0.86,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-10-09",
    "ADT": "2020-11-04",
    "ADY": 27,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0024",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 20.63,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-01-13",
    "ADT": "2023-10-03",
    "ADY": 629,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0024",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 10.35,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2022-01-13",
    "ADT": "2022-11-24",
    "ADY": 316,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0025",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 24.28,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-09-22",
    "ADT": "2023-10-01",
    "ADY": 740,
    "AGE": 83,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0025",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 5.28,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-09-22",
    "ADT": "2022-03-02",
    "ADY": 162,
    "AGE": 83,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0026",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 27.99,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-06-02",
    "ADT": "2023-10-02",
    "ADY": 853,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0026",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 27.99,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-06-02",
    "ADT": "2023-10-02",
    "ADY": 853,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0027",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 12.15,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-12-08",
    "ADT": "2022-12-13",
    "ADY": 371,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0003-0027",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.27,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-12-08",
    "ADT": "2022-02-15",
    "ADY": 70,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0004-0001",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 8.58,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-07-16",
    "ADT": "2022-04-03",
    "ADY": 262,
    "AGE": 45,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0004-0001",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 3.48,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-07-16",
    "ADT": "2021-10-30",
    "ADY": 107,
    "AGE": 45,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0004-0002",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 33.67,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-12-13",
    "ADT": "2023-10-04",
    "ADY": 1026,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0004-0002",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 13.54,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-12-13",
    "ADT": "2022-01-29",
    "ADY": 413,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0004-0003",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 23.61,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-10-08",
    "ADT": "2022-09-27",
    "ADY": 720,
    "AGE": 45,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0004-0003",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 5.37,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-10-08",
    "ADT": "2021-03-20",
    "ADY": 164,
    "AGE": 45,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0004-0004",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.24,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2022-02-11",
    "ADT": "2022-09-19",
    "ADY": 221,
    "AGE": 46,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0004-0004",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 19.71,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-02-11",
    "ADT": "2023-10-04",
    "ADY": 601,
    "AGE": 46,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0004-0005",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.77,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-03-09",
    "ADT": "2021-11-01",
    "ADY": 238,
    "AGE": 71,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0004-0005",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 17.78,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-03-09",
    "ADT": "2022-09-01",
    "ADY": 542,
    "AGE": 71,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0004-0006",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 21.12,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-12-27",
    "ADT": "2023-10-01",
    "ADY": 644,
    "AGE": 54,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0004-0006",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 10.77,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-12-27",
    "ADT": "2022-11-20",
    "ADY": 329,
    "AGE": 54,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0004-0007",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 0.71,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-07-24",
    "ADT": "2021-08-15",
    "ADY": 23,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0004-0007",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 13.96,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-07-24",
    "ADT": "2022-09-22",
    "ADY": 426,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0004-0008",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.49,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2022-02-09",
    "ADT": "2022-06-26",
    "ADY": 138,
    "AGE": 79,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0004-0008",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 6.42,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2022-02-09",
    "ADT": "2022-08-23",
    "ADY": 196,
    "AGE": 79,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0004-0009",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 5.85,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2022-03-03",
    "ADT": "2022-08-28",
    "ADY": 179,
    "AGE": 81,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0004-0009",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 6.77,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2022-03-03",
    "ADT": "2022-09-25",
    "ADY": 207,
    "AGE": 81,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0004-0010",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 29.43,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-04-21",
    "ADT": "2023-10-04",
    "ADY": 897,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0004-0010",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 29.43,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-04-21",
    "ADT": "2023-10-04",
    "ADY": 897,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0004-0011",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 0.89,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-07-19",
    "ADT": "2021-08-15",
    "ADY": 28,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0004-0011",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 26.58,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-07-19",
    "ADT": "2023-10-06",
    "ADY": 810,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0004-0012",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 3.25,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-07-30",
    "ADT": "2020-11-06",
    "ADY": 100,
    "AGE": 48,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0004-0012",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 22.79,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-07-30",
    "ADT": "2022-06-24",
    "ADY": 695,
    "AGE": 48,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0004-0013",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 3.44,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2022-01-10",
    "ADT": "2022-04-25",
    "ADY": 106,
    "AGE": 56,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0004-0013",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 20.7,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-01-10",
    "ADT": "2023-10-02",
    "ADY": 631,
    "AGE": 56,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0004-0014",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.5,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-02-25",
    "ADT": "2021-10-11",
    "ADY": 229,
    "AGE": 62,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0004-0014",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 16.85,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-02-25",
    "ADT": "2022-07-23",
    "ADY": 514,
    "AGE": 62,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0004-0015",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.83,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-04-10",
    "ADT": "2020-07-05",
    "ADY": 87,
    "AGE": 78,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0004-0015",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 4.99,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-04-10",
    "ADT": "2020-09-09",
    "ADY": 153,
    "AGE": 78,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0004-0016",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 22.77,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-11-13",
    "ADT": "2023-10-07",
    "ADY": 694,
    "AGE": 52,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0004-0016",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 22.77,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-11-13",
    "ADT": "2023-10-07",
    "ADY": 694,
    "AGE": 52,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0004-0017",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 0.94,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2022-01-22",
    "ADT": "2022-02-20",
    "ADY": 30,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0004-0017",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 20.3,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-01-22",
    "ADT": "2023-10-02",
    "ADY": 619,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0004-0018",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 31.31,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-11-19",
    "ADT": "2023-06-30",
    "ADY": 954,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0004-0018",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 34.53,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-11-19",
    "ADT": "2023-10-06",
    "ADY": 1052,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0004-0019",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 21.52,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-12-15",
    "ADT": "2023-10-01",
    "ADY": 656,
    "AGE": 83,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0004-0019",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 21.52,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-12-15",
    "ADT": "2023-10-01",
    "ADY": 656,
    "AGE": 83,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0004-0020",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 8.74,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-11-12",
    "ADT": "2022-08-05",
    "ADY": 267,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0004-0020",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 22.77,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-11-12",
    "ADT": "2023-10-06",
    "ADY": 694,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0004-0021",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.56,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-10-30",
    "ADT": "2021-03-18",
    "ADY": 140,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0004-0021",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 9.01,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-10-30",
    "ADT": "2021-07-31",
    "ADY": 275,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0004-0022",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.95,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-09-25",
    "ADT": "2022-02-23",
    "ADY": 152,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0004-0022",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 13.02,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-09-25",
    "ADT": "2022-10-26",
    "ADY": 397,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0004-0023",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 9.47,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-06-04",
    "ADT": "2021-03-19",
    "ADY": 289,
    "AGE": 79,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0004-0023",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 14.21,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-06-04",
    "ADT": "2021-08-11",
    "ADY": 434,
    "AGE": 79,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0005-0001",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 14.92,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2022-01-14",
    "ADT": "2023-04-13",
    "ADY": 455,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0005-0001",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 20.32,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2022-01-14",
    "ADT": "2023-09-25",
    "ADY": 620,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0005-0002",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 3.72,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-07-23",
    "ADT": "2021-11-13",
    "ADY": 114,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0005-0002",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 26.35,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-07-23",
    "ADT": "2023-10-03",
    "ADY": 803,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0005-0003",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.44,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-06-26",
    "ADT": "2020-09-08",
    "ADY": 75,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0005-0003",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 25.15,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-06-26",
    "ADT": "2022-08-01",
    "ADY": 767,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0005-0004",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.97,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-02-03",
    "ADT": "2021-05-04",
    "ADY": 91,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0005-0004",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 3.83,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-02-03",
    "ADT": "2021-05-31",
    "ADY": 118,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0005-0005",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 26.56,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-11-27",
    "ADT": "2023-02-13",
    "ADY": 809,
    "AGE": 84,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0005-0005",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 29.47,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-11-27",
    "ADT": "2023-05-13",
    "ADY": 898,
    "AGE": 84,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0005-0006",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 19.11,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-10-24",
    "ADT": "2023-05-29",
    "ADY": 583,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0005-0006",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 19.5,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-10-24",
    "ADT": "2023-06-10",
    "ADY": 595,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0005-0007",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 9.35,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-06-17",
    "ADT": "2022-03-29",
    "ADY": 286,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0005-0007",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 9.37,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-06-17",
    "ADT": "2022-03-29",
    "ADY": 286,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0005-0008",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 23.49,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-10-16",
    "ADT": "2023-10-01",
    "ADY": 716,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0005-0008",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 23.49,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-10-16",
    "ADT": "2023-10-01",
    "ADY": 716,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0005-0009",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 18.2,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-07-11",
    "ADT": "2023-01-16",
    "ADY": 555,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0005-0009",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 10.59,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-07-11",
    "ADT": "2022-05-29",
    "ADY": 323,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0005-0010",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 24.15,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-09-30",
    "ADT": "2023-10-05",
    "ADY": 736,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0005-0010",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 24.15,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-09-30",
    "ADT": "2023-10-05",
    "ADY": 736,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0005-0011",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 3.57,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2022-02-11",
    "ADT": "2022-05-31",
    "ADY": 110,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0005-0011",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 18.16,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2022-02-11",
    "ADT": "2023-08-18",
    "ADY": 554,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0005-0012",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.34,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-04-06",
    "ADT": "2020-08-16",
    "ADY": 133,
    "AGE": 75,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0005-0012",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 25.29,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-04-06",
    "ADT": "2022-05-16",
    "ADY": 771,
    "AGE": 75,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0005-0013",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 18.68,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-01-04",
    "ADT": "2022-07-27",
    "ADY": 570,
    "AGE": 41,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0005-0013",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 32.98,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-01-04",
    "ADT": "2023-10-05",
    "ADY": 1005,
    "AGE": 41,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0005-0014",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 23.59,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-07-13",
    "ADT": "2022-07-01",
    "ADY": 719,
    "AGE": 71,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0005-0014",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 27.83,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-07-13",
    "ADT": "2022-11-07",
    "ADY": 848,
    "AGE": 71,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0005-0015",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 18.94,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-09-30",
    "ADT": "2023-04-30",
    "ADY": 578,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0005-0015",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 24.08,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-09-30",
    "ADT": "2023-10-03",
    "ADY": 734,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0005-0016",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 5.95,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-10-24",
    "ADT": "2021-04-23",
    "ADY": 182,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0005-0016",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 9.85,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-10-24",
    "ADT": "2021-08-20",
    "ADY": 301,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0005-0017",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 24.28,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-09-24",
    "ADT": "2023-10-03",
    "ADY": 740,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0005-0017",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 24.28,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-09-24",
    "ADT": "2023-10-03",
    "ADY": 740,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0005-0018",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 1.69,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-08-29",
    "ADT": "2021-10-19",
    "ADY": 52,
    "AGE": 70,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0005-0018",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 23.06,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-08-29",
    "ADT": "2023-08-01",
    "ADY": 703,
    "AGE": 70,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0005-0019",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 8.97,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-04-20",
    "ADT": "2022-01-18",
    "ADY": 274,
    "AGE": 46,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0005-0019",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 29.47,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-04-20",
    "ADT": "2023-10-04",
    "ADY": 898,
    "AGE": 46,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0005-0020",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 16.73,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-11-08",
    "ADT": "2023-04-01",
    "ADY": 510,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0005-0020",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 22.73,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-11-08",
    "ADT": "2023-10-01",
    "ADY": 693,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0005-0021",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 3.71,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2022-01-06",
    "ADT": "2022-04-29",
    "ADY": 114,
    "AGE": 82,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0005-0021",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 9.68,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2022-01-06",
    "ADT": "2022-10-28",
    "ADY": 296,
    "AGE": 82,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0001",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 20.63,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-01-16",
    "ADT": "2023-10-06",
    "ADY": 629,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0001",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 20.34,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2022-01-16",
    "ADT": "2023-09-27",
    "ADY": 620,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0002",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.13,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-06-29",
    "ADT": "2021-02-01",
    "ADY": 218,
    "AGE": 71,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0002",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 14.84,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-06-29",
    "ADT": "2021-09-24",
    "ADY": 453,
    "AGE": 71,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0003",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 31.73,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-02-12",
    "ADT": "2023-10-06",
    "ADY": 967,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0003",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 31.73,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-02-12",
    "ADT": "2023-10-06",
    "ADY": 967,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0004",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 22.3,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-11-21",
    "ADT": "2022-10-01",
    "ADY": 680,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0004",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 34.43,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-11-21",
    "ADT": "2023-10-05",
    "ADY": 1049,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0005",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 6.96,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-04-22",
    "ADT": "2021-11-20",
    "ADY": 213,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0005",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 22.13,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-04-22",
    "ADT": "2023-02-25",
    "ADY": 675,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0006",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.28,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-05-21",
    "ADT": "2021-09-28",
    "ADY": 131,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0006",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 28.38,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-05-21",
    "ADT": "2023-10-02",
    "ADY": 865,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0007",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 23.98,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-10-01",
    "ADT": "2023-10-01",
    "ADY": 731,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0007",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 23.98,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-10-01",
    "ADT": "2023-10-01",
    "ADY": 731,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0008",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 1.3,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-09-16",
    "ADT": "2020-10-26",
    "ADY": 41,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0008",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 36.6,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-09-16",
    "ADT": "2023-10-05",
    "ADY": 1115,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0009",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 20.83,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-01-11",
    "ADT": "2023-10-07",
    "ADY": 635,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0009",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 20.83,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-01-11",
    "ADT": "2023-10-07",
    "ADY": 635,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0010",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 19.26,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2022-02-05",
    "ADT": "2023-09-14",
    "ADY": 587,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0010",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 19.94,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-02-05",
    "ADT": "2023-10-05",
    "ADY": 608,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0011",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 8.08,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-07-04",
    "ADT": "2021-03-07",
    "ADY": 247,
    "AGE": 82,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0011",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.53,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-07-04",
    "ADT": "2020-09-19",
    "ADY": 78,
    "AGE": 82,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0012",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 30.68,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-03-11",
    "ADT": "2023-10-01",
    "ADY": 935,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0012",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 30.68,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-03-11",
    "ADT": "2023-10-01",
    "ADY": 935,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0013",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 26.56,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-09-18",
    "ADT": "2022-12-05",
    "ADY": 809,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0013",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 36.4,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-09-18",
    "ADT": "2023-10-01",
    "ADY": 1109,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0014",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 9.79,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2022-02-25",
    "ADT": "2022-12-20",
    "ADY": 299,
    "AGE": 84,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0014",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 11.98,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2022-02-25",
    "ADT": "2023-02-25",
    "ADY": 366,
    "AGE": 84,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0015",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 14.07,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-03-08",
    "ADT": "2022-05-10",
    "ADY": 429,
    "AGE": 79,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0015",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 1.69,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-03-08",
    "ADT": "2021-04-28",
    "ADY": 52,
    "AGE": 79,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0016",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 41.82,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-04-10",
    "ADT": "2023-10-05",
    "ADY": 1274,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0016",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 23.15,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-04-10",
    "ADT": "2022-03-16",
    "ADY": 706,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0017",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 31.83,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-02-05",
    "ADT": "2023-10-02",
    "ADY": 970,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0017",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 31.87,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-02-05",
    "ADT": "2023-10-03",
    "ADY": 971,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0018",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 3.43,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-03-31",
    "ADT": "2020-07-13",
    "ADY": 105,
    "AGE": 75,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0018",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 42.21,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-03-31",
    "ADT": "2023-10-07",
    "ADY": 1286,
    "AGE": 75,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0019",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 20.14,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-01-29",
    "ADT": "2023-10-04",
    "ADY": 614,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0019",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 20.14,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-01-29",
    "ADT": "2023-10-04",
    "ADY": 614,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0020",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 14.98,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-12-23",
    "ADT": "2022-03-24",
    "ADY": 457,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0020",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.92,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-12-23",
    "ADT": "2021-08-21",
    "ADY": 242,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0021",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 10.16,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-12-22",
    "ADT": "2021-10-27",
    "ADY": 310,
    "AGE": 70,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0021",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 21.2,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-12-22",
    "ADT": "2022-09-28",
    "ADY": 646,
    "AGE": 70,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0022",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 0.65,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-03-26",
    "ADT": "2021-04-15",
    "ADY": 21,
    "AGE": 62,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0022",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 26.52,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-03-26",
    "ADT": "2023-06-11",
    "ADY": 808,
    "AGE": 62,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0023",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 26.77,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-04-04",
    "ADT": "2022-06-28",
    "ADY": 816,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0023",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 36.85,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-04-04",
    "ADT": "2023-05-01",
    "ADY": 1123,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0024",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 26.46,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-06-14",
    "ADT": "2023-08-28",
    "ADY": 806,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0024",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 6.54,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-06-14",
    "ADT": "2021-12-30",
    "ADY": 200,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0025",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 21.58,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-03-07",
    "ADT": "2021-12-24",
    "ADY": 658,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0025",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 35.5,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-03-07",
    "ADT": "2023-02-21",
    "ADY": 1082,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0026",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 8.98,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-09-26",
    "ADT": "2022-06-26",
    "ADY": 274,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0026",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 21.23,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-09-26",
    "ADT": "2023-07-04",
    "ADY": 647,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0027",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 3.83,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-06-11",
    "ADT": "2021-10-06",
    "ADY": 118,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0027",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 7.96,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-06-11",
    "ADT": "2022-02-08",
    "ADY": 243,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0028",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 24.1,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-05-20",
    "ADT": "2023-05-24",
    "ADY": 735,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0028",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 13.79,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-05-20",
    "ADT": "2022-07-14",
    "ADY": 421,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0029",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 30.29,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-03-28",
    "ADT": "2023-10-06",
    "ADY": 923,
    "AGE": 56,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0029",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.38,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-03-28",
    "ADT": "2021-06-08",
    "ADY": 73,
    "AGE": 56,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0030",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 9.02,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-04-27",
    "ADT": "2021-01-27",
    "ADY": 276,
    "AGE": 76,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0006-0030",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 9.32,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-04-27",
    "ADT": "2021-02-05",
    "ADY": 285,
    "AGE": 76,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0001",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 15.47,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-11-20",
    "ADT": "2023-03-06",
    "ADY": 472,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0001",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 22.44,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-11-20",
    "ADT": "2023-10-04",
    "ADY": 684,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0002",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 19.48,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-05-26",
    "ADT": "2023-01-09",
    "ADY": 594,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0002",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 28.29,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-05-26",
    "ADT": "2023-10-04",
    "ADY": 862,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0003",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 1.15,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-02-26",
    "ADT": "2021-04-02",
    "ADY": 36,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0003",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 1.15,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-02-26",
    "ADT": "2021-04-02",
    "ADY": 36,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0004",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.02,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-03-28",
    "ADT": "2020-10-28",
    "ADY": 215,
    "AGE": 76,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0004",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 7.82,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-03-28",
    "ADT": "2020-11-21",
    "ADY": 239,
    "AGE": 76,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0005",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.83,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-08-04",
    "ADT": "2020-10-29",
    "ADY": 87,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0005",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 3.69,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-08-04",
    "ADT": "2020-11-24",
    "ADY": 113,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0006",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 10.8,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-06-01",
    "ADT": "2021-04-26",
    "ADY": 330,
    "AGE": 82,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0006",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 28.23,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-06-01",
    "ADT": "2022-10-08",
    "ADY": 860,
    "AGE": 82,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0007",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 20.76,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-05-02",
    "ADT": "2022-01-24",
    "ADY": 633,
    "AGE": 47,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0007",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 13.53,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-05-02",
    "ADT": "2021-06-18",
    "ADY": 413,
    "AGE": 47,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0008",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 0.7,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-07-17",
    "ADT": "2020-08-07",
    "ADY": 22,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0008",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 15.5,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-07-17",
    "ADT": "2021-11-01",
    "ADY": 473,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0009",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 21.78,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-04-10",
    "ADT": "2023-02-02",
    "ADY": 664,
    "AGE": 87,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0009",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 29.76,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-04-10",
    "ADT": "2023-10-03",
    "ADY": 907,
    "AGE": 87,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0010",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.61,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-10-09",
    "ADT": "2020-12-27",
    "ADY": 80,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0010",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 20.92,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-10-09",
    "ADT": "2022-07-08",
    "ADY": 638,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0011",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 24.87,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-09-06",
    "ADT": "2023-10-03",
    "ADY": 758,
    "AGE": 56,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0011",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 24.87,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-09-06",
    "ADT": "2023-10-03",
    "ADY": 758,
    "AGE": 56,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0012",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 20.6,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-01-16",
    "ADT": "2023-10-05",
    "ADY": 628,
    "AGE": 77,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0012",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 20.6,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-01-16",
    "ADT": "2023-10-05",
    "ADY": 628,
    "AGE": 77,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0013",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 31.41,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-02-17",
    "ADT": "2023-10-01",
    "ADY": 957,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0013",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 16.76,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-02-17",
    "ADT": "2022-07-12",
    "ADY": 511,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0014",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 1.55,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-11-01",
    "ADT": "2020-12-18",
    "ADY": 48,
    "AGE": 42,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0014",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 35.12,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-11-01",
    "ADT": "2023-10-06",
    "ADY": 1070,
    "AGE": 42,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0015",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 5.95,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-12-31",
    "ADT": "2021-06-30",
    "ADY": 182,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0015",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 10.22,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-12-31",
    "ADT": "2021-11-07",
    "ADY": 312,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0016",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 40.63,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-05-02",
    "ADT": "2023-09-21",
    "ADY": 1238,
    "AGE": 51,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0016",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 41.1,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-05-02",
    "ADT": "2023-10-05",
    "ADY": 1252,
    "AGE": 51,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0017",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 15.52,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-08-08",
    "ADT": "2021-11-23",
    "ADY": 473,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0017",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 1.86,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-08-08",
    "ADT": "2020-10-04",
    "ADY": 58,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0018",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 40.24,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-05-26",
    "ADT": "2023-10-03",
    "ADY": 1226,
    "AGE": 84,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0018",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 40.24,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-05-26",
    "ADT": "2023-10-03",
    "ADY": 1226,
    "AGE": 84,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0019",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.02,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-07-14",
    "ADT": "2020-11-13",
    "ADY": 123,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0019",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 25.34,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-07-14",
    "ADT": "2022-08-24",
    "ADY": 772,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0020",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.4,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-06-24",
    "ADT": "2022-02-04",
    "ADY": 226,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0020",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 14.91,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-06-24",
    "ADT": "2022-09-21",
    "ADY": 455,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0021",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 27.33,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-06-13",
    "ADT": "2022-09-23",
    "ADY": 833,
    "AGE": 62,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0021",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 0.61,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-06-13",
    "ADT": "2020-07-02",
    "ADY": 20,
    "AGE": 62,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0022",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 3.67,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-12-13",
    "ADT": "2022-04-04",
    "ADY": 113,
    "AGE": 56,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0022",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 4.85,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-12-13",
    "ADT": "2022-05-10",
    "ADY": 149,
    "AGE": 56,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0023",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 11.47,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-06-05",
    "ADT": "2022-05-20",
    "ADY": 350,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0023",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 27.95,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-06-05",
    "ADT": "2023-10-04",
    "ADY": 852,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0024",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 0.39,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-08-29",
    "ADT": "2021-09-10",
    "ADY": 13,
    "AGE": 62,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0024",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 25.26,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-08-29",
    "ADT": "2023-10-07",
    "ADY": 770,
    "AGE": 62,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0025",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 35.81,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-10-09",
    "ADT": "2023-10-04",
    "ADY": 1091,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0025",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 10.85,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-10-09",
    "ADT": "2021-09-04",
    "ADY": 331,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0026",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 33.51,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-12-15",
    "ADT": "2023-10-01",
    "ADY": 1021,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0026",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 21.04,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-12-15",
    "ADT": "2022-09-16",
    "ADY": 641,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0027",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 20.77,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-11-12",
    "ADT": "2023-08-06",
    "ADY": 633,
    "AGE": 79,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0027",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 22.7,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-11-12",
    "ADT": "2023-10-04",
    "ADY": 692,
    "AGE": 79,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0028",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 40.47,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-05-23",
    "ADT": "2023-10-07",
    "ADY": 1233,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0028",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 40.47,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-05-23",
    "ADT": "2023-10-07",
    "ADY": 1233,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0029",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 38.55,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-03-06",
    "ADT": "2023-05-23",
    "ADY": 1174,
    "AGE": 71,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0029",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 42.97,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-03-06",
    "ADT": "2023-10-05",
    "ADY": 1309,
    "AGE": 71,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0030",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 27.78,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-09-12",
    "ADT": "2023-01-06",
    "ADY": 847,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0030",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 23.25,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-09-12",
    "ADT": "2022-08-21",
    "ADY": 709,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0031",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 15.99,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-08-17",
    "ADT": "2021-12-17",
    "ADY": 488,
    "AGE": 84,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0031",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 21.2,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-08-17",
    "ADT": "2022-05-24",
    "ADY": 646,
    "AGE": 84,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0032",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 23.49,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-10-16",
    "ADT": "2023-10-01",
    "ADY": 716,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0032",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 23.49,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-10-16",
    "ADT": "2023-10-01",
    "ADY": 716,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0033",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 1.86,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-05-27",
    "ADT": "2021-07-23",
    "ADY": 58,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0007-0033",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 8.44,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-05-27",
    "ADT": "2022-02-08",
    "ADY": 258,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0008-0001",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 12.76,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-08-25",
    "ADT": "2021-09-17",
    "ADY": 389,
    "AGE": 48,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0008-0001",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.49,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-08-25",
    "ADT": "2021-04-10",
    "ADY": 229,
    "AGE": 48,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0008-0002",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 0.73,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2022-01-13",
    "ADT": "2022-02-04",
    "ADY": 23,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0008-0002",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 20.6,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-01-13",
    "ADT": "2023-10-02",
    "ADY": 628,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0008-0003",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 27.22,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-03-01",
    "ADT": "2023-06-08",
    "ADY": 830,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0008-0003",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 31.18,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-03-01",
    "ADT": "2023-10-06",
    "ADY": 950,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0008-0004",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.24,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-12-28",
    "ADT": "2022-03-06",
    "ADY": 69,
    "AGE": 56,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0008-0004",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 21.29,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-12-28",
    "ADT": "2023-10-07",
    "ADY": 649,
    "AGE": 56,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0008-0005",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 11.45,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-08-22",
    "ADT": "2021-08-06",
    "ADY": 350,
    "AGE": 78,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0008-0005",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 0.7,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-08-22",
    "ADT": "2020-09-12",
    "ADY": 22,
    "AGE": 78,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0008-0006",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 6.17,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-12-14",
    "ADT": "2022-06-20",
    "ADY": 189,
    "AGE": 71,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0008-0006",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.12,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-12-14",
    "ADT": "2022-04-18",
    "ADY": 126,
    "AGE": 71,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0008-0007",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 28.75,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-03-19",
    "ADT": "2023-08-11",
    "ADY": 876,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0008-0007",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 30.55,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-03-19",
    "ADT": "2023-10-05",
    "ADY": 931,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0008-0008",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 25.09,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-03-07",
    "ADT": "2023-04-10",
    "ADY": 765,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0008-0008",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 30.91,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-03-07",
    "ADT": "2023-10-04",
    "ADY": 942,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0008-0009",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 29.89,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-04-05",
    "ADT": "2023-10-02",
    "ADY": 911,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0008-0009",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 29.89,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-04-05",
    "ADT": "2023-10-02",
    "ADY": 911,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0008-0010",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 24.38,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-10-15",
    "ADT": "2022-10-27",
    "ADY": 743,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0008-0010",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 18.52,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-10-15",
    "ADT": "2022-05-02",
    "ADY": 565,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0008-0011",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 36.37,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-09-19",
    "ADT": "2023-10-01",
    "ADY": 1108,
    "AGE": 86,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0008-0011",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 36.37,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-09-19",
    "ADT": "2023-10-01",
    "ADY": 1108,
    "AGE": 86,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0008-0012",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 33.21,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-12-28",
    "ADT": "2023-10-05",
    "ADY": 1012,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0008-0012",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 33.21,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-12-28",
    "ADT": "2023-10-05",
    "ADY": 1012,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0008-0013",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 3.32,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2022-02-26",
    "ADT": "2022-06-07",
    "ADY": 102,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0008-0013",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 4.86,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2022-02-26",
    "ADT": "2022-07-24",
    "ADY": 149,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0008-0014",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 11.73,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-10-20",
    "ADT": "2022-10-12",
    "ADY": 358,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0008-0014",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 6.82,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-10-20",
    "ADT": "2022-05-16",
    "ADY": 209,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0008-0015",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.16,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-06-15",
    "ADT": "2020-08-20",
    "ADY": 67,
    "AGE": 62,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0008-0015",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 18.13,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-06-15",
    "ADT": "2021-12-19",
    "ADY": 553,
    "AGE": 62,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0008-0016",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 11.47,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-02-09",
    "ADT": "2022-01-24",
    "ADY": 350,
    "AGE": 62,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0008-0016",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 31.87,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-02-09",
    "ADT": "2023-10-07",
    "ADY": 971,
    "AGE": 62,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0008-0017",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 10.72,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-06-07",
    "ADT": "2022-04-29",
    "ADY": 327,
    "AGE": 71,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0008-0017",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 27.89,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-06-07",
    "ADT": "2023-10-04",
    "ADY": 850,
    "AGE": 71,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0008-0018",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 18.01,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-04-28",
    "ADT": "2021-10-28",
    "ADY": 549,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0008-0018",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 10.44,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-04-28",
    "ADT": "2021-03-12",
    "ADY": 319,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0008-0019",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.63,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-01-30",
    "ADT": "2021-06-20",
    "ADY": 142,
    "AGE": 81,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0008-0019",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 7.06,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-01-30",
    "ADT": "2021-09-02",
    "ADY": 216,
    "AGE": 81,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0008-0020",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 12.61,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-05-10",
    "ADT": "2022-05-29",
    "ADY": 385,
    "AGE": 48,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0008-0020",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.91,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-05-10",
    "ADT": "2022-01-06",
    "ADY": 242,
    "AGE": 48,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0008-0021",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 33.34,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-12-20",
    "ADT": "2023-10-01",
    "ADY": 1016,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0008-0021",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 33.34,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-12-20",
    "ADT": "2023-10-01",
    "ADY": 1016,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0008-0022",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 26.48,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-05-01",
    "ADT": "2022-07-16",
    "ADY": 807,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0008-0022",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 27.34,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-05-01",
    "ADT": "2022-08-11",
    "ADY": 833,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0008-0023",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 0.14,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-03-03",
    "ADT": "2021-03-07",
    "ADY": 5,
    "AGE": 70,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0008-0023",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 4.21,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-03-03",
    "ADT": "2021-07-09",
    "ADY": 129,
    "AGE": 70,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0009-0001",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.36,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-06-27",
    "ADT": "2021-02-06",
    "ADY": 225,
    "AGE": 70,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0009-0001",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 34.1,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-06-27",
    "ADT": "2023-05-01",
    "ADY": 1039,
    "AGE": 70,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0009-0002",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.86,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-11-04",
    "ADT": "2022-07-01",
    "ADY": 240,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0009-0002",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 10.51,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-11-04",
    "ADT": "2022-09-20",
    "ADY": 321,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0009-0003",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 0.95,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-07-28",
    "ADT": "2020-08-26",
    "ADY": 30,
    "AGE": 62,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0009-0003",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 3.48,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-07-28",
    "ADT": "2020-11-11",
    "ADY": 107,
    "AGE": 62,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0009-0004",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 11.37,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-08-20",
    "ADT": "2022-08-01",
    "ADY": 347,
    "AGE": 71,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0009-0004",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 25.46,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-08-20",
    "ADT": "2023-10-04",
    "ADY": 776,
    "AGE": 71,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0009-0005",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 11.77,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-09-25",
    "ADT": "2021-09-18",
    "ADY": 359,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0009-0005",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 36.17,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-09-25",
    "ADT": "2023-10-01",
    "ADY": 1102,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0009-0006",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 5.11,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-11-11",
    "ADT": "2021-04-16",
    "ADY": 157,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0009-0006",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 34.72,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-11-11",
    "ADT": "2023-10-04",
    "ADY": 1058,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0009-0007",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.93,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2022-02-04",
    "ADT": "2022-07-04",
    "ADY": 151,
    "AGE": 78,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0009-0007",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 12.6,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2022-02-04",
    "ADT": "2023-02-23",
    "ADY": 385,
    "AGE": 78,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0009-0008",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 12.52,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2022-01-27",
    "ADT": "2023-02-12",
    "ADY": 382,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0009-0008",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 20.3,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-01-27",
    "ADT": "2023-10-07",
    "ADY": 619,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0009-0009",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 10.47,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-02-20",
    "ADT": "2022-01-05",
    "ADY": 320,
    "AGE": 49,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0009-0009",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 25.8,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-02-20",
    "ADT": "2023-04-16",
    "ADY": 786,
    "AGE": 49,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0009-0010",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 42.74,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-03-12",
    "ADT": "2023-10-04",
    "ADY": 1302,
    "AGE": 62,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0009-0010",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 42.74,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-03-12",
    "ADT": "2023-10-04",
    "ADY": 1302,
    "AGE": 62,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0009-0011",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.58,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-04-22",
    "ADT": "2020-12-09",
    "ADY": 232,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0009-0011",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 11.61,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-04-22",
    "ADT": "2021-04-10",
    "ADY": 354,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0009-0012",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 18.52,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-04-08",
    "ADT": "2022-10-24",
    "ADY": 565,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0009-0012",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 22.04,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-04-08",
    "ADT": "2023-02-08",
    "ADY": 672,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0009-0013",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 6.83,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-11-29",
    "ADT": "2022-06-25",
    "ADY": 209,
    "AGE": 70,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0009-0013",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 22.14,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-11-29",
    "ADT": "2023-10-04",
    "ADY": 675,
    "AGE": 70,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0009-0014",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 14.55,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-04-21",
    "ADT": "2022-07-08",
    "ADY": 444,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0009-0014",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 29.47,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-04-21",
    "ADT": "2023-10-05",
    "ADY": 898,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0009-0015",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.28,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-02-02",
    "ADT": "2021-06-12",
    "ADY": 131,
    "AGE": 77,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0009-0015",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 16.21,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-02-02",
    "ADT": "2022-06-10",
    "ADY": 494,
    "AGE": 77,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0009-0016",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 10.71,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-09-07",
    "ADT": "2021-07-30",
    "ADY": 327,
    "AGE": 86,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0009-0016",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 36.86,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-09-07",
    "ADT": "2023-10-04",
    "ADY": 1123,
    "AGE": 86,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0009-0017",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 13.46,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-09-13",
    "ADT": "2021-10-28",
    "ADY": 411,
    "AGE": 76,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0009-0017",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 23.3,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-09-13",
    "ADT": "2022-08-23",
    "ADY": 710,
    "AGE": 76,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0009-0018",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.41,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-10-16",
    "ADT": "2021-12-28",
    "ADY": 74,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0009-0018",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 9.86,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-10-16",
    "ADT": "2022-08-12",
    "ADY": 301,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0009-0019",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 12.28,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-10-25",
    "ADT": "2021-11-03",
    "ADY": 375,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0009-0019",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 13.23,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-10-25",
    "ADT": "2021-12-02",
    "ADY": 404,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0001",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 24.21,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-09-26",
    "ADT": "2023-10-03",
    "ADY": 738,
    "AGE": 56,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0001",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 24.21,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-09-26",
    "ADT": "2023-10-03",
    "ADY": 738,
    "AGE": 56,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0002",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.14,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-06-24",
    "ADT": "2022-01-27",
    "ADY": 218,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0002",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 27.43,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-06-24",
    "ADT": "2023-10-07",
    "ADY": 836,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0003",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.59,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-07-28",
    "ADT": "2020-12-15",
    "ADY": 141,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0003",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 13.05,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-07-28",
    "ADT": "2021-08-29",
    "ADY": 398,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0004",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 8.82,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-09-01",
    "ADT": "2022-05-27",
    "ADY": 269,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0004",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.31,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-09-01",
    "ADT": "2021-11-10",
    "ADY": 71,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0005",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 18.67,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-10-15",
    "ADT": "2023-05-06",
    "ADY": 569,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0005",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 23.59,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-10-15",
    "ADT": "2023-10-03",
    "ADY": 719,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0006",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 0.64,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-03-19",
    "ADT": "2021-04-07",
    "ADY": 20,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0006",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 9.38,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-03-19",
    "ADT": "2021-12-30",
    "ADY": 287,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0007",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.28,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-02-03",
    "ADT": "2021-04-13",
    "ADY": 70,
    "AGE": 50,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0007",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 12.96,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-02-03",
    "ADT": "2022-03-05",
    "ADY": 396,
    "AGE": 50,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0008",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 3.98,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2022-01-22",
    "ADT": "2022-05-23",
    "ADY": 122,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0008",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 20.37,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-01-22",
    "ADT": "2023-10-04",
    "ADY": 621,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0009",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 8.14,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-03-28",
    "ADT": "2021-12-01",
    "ADY": 249,
    "AGE": 78,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0009",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 30.16,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-03-28",
    "ADT": "2023-10-02",
    "ADY": 919,
    "AGE": 78,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0010",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.62,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-09-28",
    "ADT": "2022-05-18",
    "ADY": 233,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0010",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 14.69,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-09-28",
    "ADT": "2022-12-19",
    "ADY": 448,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0011",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.14,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-08-25",
    "ADT": "2020-10-29",
    "ADY": 66,
    "AGE": 76,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0011",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 4.44,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-08-25",
    "ADT": "2021-01-07",
    "ADY": 136,
    "AGE": 76,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0012",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 5.68,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-12-09",
    "ADT": "2021-05-31",
    "ADY": 174,
    "AGE": 62,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0012",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 6.44,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-12-09",
    "ADT": "2021-06-23",
    "ADY": 197,
    "AGE": 62,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0013",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 36.2,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-09-24",
    "ADT": "2023-10-01",
    "ADY": 1103,
    "AGE": 88,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0013",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 36.2,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-09-24",
    "ADT": "2023-10-01",
    "ADY": 1103,
    "AGE": 88,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0014",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 23.59,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-04-12",
    "ADT": "2022-03-31",
    "ADY": 719,
    "AGE": 76,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0014",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 25.04,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-04-12",
    "ADT": "2022-05-14",
    "ADY": 763,
    "AGE": 76,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0015",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 23.06,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-10-29",
    "ADT": "2023-10-01",
    "ADY": 703,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0015",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 23.06,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-10-29",
    "ADT": "2023-10-01",
    "ADY": 703,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0016",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 14.71,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-08-18",
    "ADT": "2022-11-09",
    "ADY": 449,
    "AGE": 80,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0016",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 25.46,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-08-18",
    "ADT": "2023-10-02",
    "ADY": 776,
    "AGE": 80,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0017",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 16.53,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-07-06",
    "ADT": "2022-11-21",
    "ADY": 504,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0017",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.91,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-07-06",
    "ADT": "2022-03-04",
    "ADY": 242,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0018",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 10.76,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2022-01-27",
    "ADT": "2022-12-21",
    "ADY": 329,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0018",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 20.14,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-01-27",
    "ADT": "2023-10-02",
    "ADY": 614,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0019",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 41.03,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-05-03",
    "ADT": "2023-10-04",
    "ADY": 1250,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0019",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 41.03,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-05-03",
    "ADT": "2023-10-04",
    "ADY": 1250,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0020",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 25.7,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-04-12",
    "ADT": "2023-06-03",
    "ADY": 783,
    "AGE": 76,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0020",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 29.45,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-04-12",
    "ADT": "2023-09-25",
    "ADY": 897,
    "AGE": 76,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0021",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 12.51,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-12-07",
    "ADT": "2022-12-23",
    "ADY": 382,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0021",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 21.94,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-12-07",
    "ADT": "2023-10-06",
    "ADY": 669,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0022",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 3.95,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-06-29",
    "ADT": "2021-10-27",
    "ADY": 121,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0022",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 10.53,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-06-29",
    "ADT": "2022-05-16",
    "ADY": 322,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0023",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 14.68,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-06-07",
    "ADT": "2021-08-28",
    "ADY": 448,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0023",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 12.27,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-06-07",
    "ADT": "2021-06-15",
    "ADY": 374,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0024",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 26.6,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-05-03",
    "ADT": "2023-07-22",
    "ADY": 811,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0010-0024",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 29.04,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-05-03",
    "ADT": "2023-10-04",
    "ADY": 885,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0001",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 9.8,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-04-10",
    "ADT": "2021-02-02",
    "ADY": 299,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0001",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 41.79,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-04-10",
    "ADT": "2023-10-04",
    "ADY": 1273,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0002",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 11.1,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-10-27",
    "ADT": "2021-09-30",
    "ADY": 339,
    "AGE": 50,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0002",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 12.51,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-10-27",
    "ADT": "2021-11-12",
    "ADY": 382,
    "AGE": 50,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0003",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 35.87,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-10-08",
    "ADT": "2023-10-05",
    "ADY": 1093,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0003",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 35.87,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-10-08",
    "ADT": "2023-10-05",
    "ADY": 1093,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0004",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 9.07,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-08-05",
    "ADT": "2021-05-08",
    "ADY": 277,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0004",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 14.52,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-08-05",
    "ADT": "2021-10-21",
    "ADY": 443,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0005",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 11.34,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-06-30",
    "ADT": "2021-06-10",
    "ADY": 346,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0005",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 29.12,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-06-30",
    "ADT": "2022-12-03",
    "ADY": 887,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0006",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 28.45,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-05-22",
    "ADT": "2023-10-05",
    "ADY": 867,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0006",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 28.45,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-05-22",
    "ADT": "2023-10-05",
    "ADY": 867,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0007",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 19.91,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-02-03",
    "ADT": "2023-10-02",
    "ADY": 607,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0007",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 19.91,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-02-03",
    "ADT": "2023-10-02",
    "ADY": 607,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0008",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 30.22,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-03-26",
    "ADT": "2023-10-02",
    "ADY": 921,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0008",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 30.22,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-03-26",
    "ADT": "2023-10-02",
    "ADY": 921,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0009",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 15.49,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-06-08",
    "ADT": "2021-09-23",
    "ADY": 473,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0009",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 34.81,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-06-08",
    "ADT": "2023-05-04",
    "ADY": 1061,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0010",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 6.34,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2022-01-20",
    "ADT": "2022-08-01",
    "ADY": 194,
    "AGE": 49,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0010",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 16.68,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2022-01-20",
    "ADT": "2023-06-12",
    "ADY": 509,
    "AGE": 49,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0011",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 5.79,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-09-14",
    "ADT": "2021-03-09",
    "ADY": 177,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0011",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 36.53,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-09-14",
    "ADT": "2023-10-01",
    "ADY": 1113,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0012",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 29.04,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-05-05",
    "ADT": "2023-10-06",
    "ADY": 885,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0012",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 29.04,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-05-05",
    "ADT": "2023-10-06",
    "ADY": 885,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0013",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 31.44,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-02-22",
    "ADT": "2023-10-07",
    "ADY": 958,
    "AGE": 86,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0013",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 31.44,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-02-22",
    "ADT": "2023-10-07",
    "ADY": 958,
    "AGE": 86,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0014",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 3.89,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-05-12",
    "ADT": "2020-09-07",
    "ADY": 119,
    "AGE": 47,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0014",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 9.55,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-05-12",
    "ADT": "2021-02-27",
    "ADY": 292,
    "AGE": 47,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0015",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 10.03,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-03-17",
    "ADT": "2022-01-16",
    "ADY": 306,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0015",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 15.36,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-03-17",
    "ADT": "2022-06-28",
    "ADY": 469,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0016",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 15.51,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-05-08",
    "ADT": "2022-08-23",
    "ADY": 473,
    "AGE": 79,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0016",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 13.19,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-05-08",
    "ADT": "2022-06-14",
    "ADY": 403,
    "AGE": 79,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0017",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 14.75,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-01-09",
    "ADT": "2022-04-03",
    "ADY": 450,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0017",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 15.01,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-01-09",
    "ADT": "2022-04-11",
    "ADY": 458,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0018",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.58,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-04-04",
    "ADT": "2021-08-21",
    "ADY": 140,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0018",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 29.96,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-04-04",
    "ADT": "2023-10-03",
    "ADY": 913,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0019",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 1.5,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2022-02-20",
    "ADT": "2022-04-07",
    "ADY": 47,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0019",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 14.9,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2022-02-20",
    "ADT": "2023-05-20",
    "ADY": 455,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0020",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 25.33,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-08-26",
    "ADT": "2023-10-06",
    "ADY": 772,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0020",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 25.33,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-08-26",
    "ADT": "2023-10-06",
    "ADY": 772,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0021",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 20.01,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-01-31",
    "ADT": "2023-10-02",
    "ADY": 610,
    "AGE": 90,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0021",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 18.81,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2022-01-31",
    "ADT": "2023-08-27",
    "ADY": 574,
    "AGE": 90,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0022",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 10.29,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-08-14",
    "ADT": "2021-06-23",
    "ADY": 314,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0022",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 28.05,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-08-14",
    "ADT": "2022-12-16",
    "ADY": 855,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0023",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.58,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-12-30",
    "ADT": "2021-05-18",
    "ADY": 140,
    "AGE": 50,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0023",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 8.42,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-12-30",
    "ADT": "2021-09-12",
    "ADY": 257,
    "AGE": 50,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0024",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 21.91,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-12-07",
    "ADT": "2023-10-05",
    "ADY": 668,
    "AGE": 51,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0024",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 21.91,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-12-07",
    "ADT": "2023-10-05",
    "ADY": 668,
    "AGE": 51,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0025",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 3.61,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-11-03",
    "ADT": "2022-02-21",
    "ADY": 111,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0011-0025",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.37,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-11-03",
    "ADT": "2022-01-14",
    "ADY": 73,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0001",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 3.99,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-06-11",
    "ADT": "2021-10-10",
    "ADY": 122,
    "AGE": 46,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0001",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 5.14,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-06-11",
    "ADT": "2021-11-14",
    "ADY": 157,
    "AGE": 46,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0002",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 1.83,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-09-05",
    "ADT": "2021-10-31",
    "ADY": 57,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0002",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 23.41,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-09-05",
    "ADT": "2023-08-19",
    "ADY": 714,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0003",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 5.9,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-04-27",
    "ADT": "2020-10-24",
    "ADY": 181,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0003",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 8.13,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-04-27",
    "ADT": "2020-12-30",
    "ADY": 248,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0004",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 22.08,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-11-29",
    "ADT": "2023-10-02",
    "ADY": 673,
    "AGE": 43,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0004",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.35,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-11-29",
    "ADT": "2022-02-09",
    "ADY": 73,
    "AGE": 43,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0005",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 36.58,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-05-28",
    "ADT": "2023-06-15",
    "ADY": 1114,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0005",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 40.31,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-05-28",
    "ADT": "2023-10-07",
    "ADY": 1228,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0006",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 22.5,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-01-31",
    "ADT": "2022-12-17",
    "ADY": 686,
    "AGE": 62,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0006",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 29.19,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-01-31",
    "ADT": "2023-07-09",
    "ADY": 890,
    "AGE": 62,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0007",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 17.89,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-07-04",
    "ADT": "2021-12-31",
    "ADY": 546,
    "AGE": 56,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0007",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 19.4,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-07-04",
    "ADT": "2022-02-15",
    "ADY": 592,
    "AGE": 56,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0008",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 21.85,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-12-09",
    "ADT": "2023-10-05",
    "ADY": 666,
    "AGE": 74,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0008",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 14.98,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-12-09",
    "ADT": "2023-03-10",
    "ADY": 457,
    "AGE": 74,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0009",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 1.12,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-11-28",
    "ADT": "2022-01-01",
    "ADY": 35,
    "AGE": 47,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0009",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 1.89,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-11-28",
    "ADT": "2022-01-25",
    "ADY": 59,
    "AGE": 47,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0010",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 15.88,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-05-03",
    "ADT": "2021-08-29",
    "ADY": 484,
    "AGE": 78,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0010",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.68,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-05-03",
    "ADT": "2020-12-23",
    "ADY": 235,
    "AGE": 78,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0011",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 9.22,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-03-18",
    "ADT": "2020-12-24",
    "ADY": 282,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0011",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 42.27,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-03-18",
    "ADT": "2023-09-26",
    "ADY": 1288,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0012",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 17.48,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2022-02-25",
    "ADT": "2023-08-11",
    "ADY": 533,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0012",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 18.26,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2022-02-25",
    "ADT": "2023-09-04",
    "ADY": 557,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0013",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 6.92,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-11-28",
    "ADT": "2021-06-27",
    "ADY": 212,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0013",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 34.2,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-11-28",
    "ADT": "2023-10-05",
    "ADY": 1042,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0014",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 14.93,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-01-11",
    "ADT": "2022-04-10",
    "ADY": 455,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0014",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 9.12,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-01-11",
    "ADT": "2021-10-16",
    "ADY": 279,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0015",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.81,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-03-09",
    "ADT": "2021-08-02",
    "ADY": 147,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0015",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 21.53,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-03-09",
    "ADT": "2022-12-24",
    "ADY": 656,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0016",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 32.82,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-01-07",
    "ADT": "2023-10-03",
    "ADY": 1000,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0016",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 32.82,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-01-07",
    "ADT": "2023-10-03",
    "ADY": 1000,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0017",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 23.03,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-11-02",
    "ADT": "2023-10-04",
    "ADY": 702,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0017",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 23.03,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-11-02",
    "ADT": "2023-10-04",
    "ADY": 702,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0018",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 35.41,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-10-18",
    "ADT": "2023-10-01",
    "ADY": 1079,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0018",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 9.2,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-10-18",
    "ADT": "2021-07-25",
    "ADY": 281,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0019",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 9.82,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-09-17",
    "ADT": "2022-07-13",
    "ADY": 300,
    "AGE": 45,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0019",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 17.37,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-09-17",
    "ADT": "2023-02-28",
    "ADY": 530,
    "AGE": 45,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0020",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 27.75,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-10-20",
    "ADT": "2023-02-12",
    "ADY": 846,
    "AGE": 62,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0020",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 35.41,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-10-20",
    "ADT": "2023-10-03",
    "ADY": 1079,
    "AGE": 62,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0021",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 6.93,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-09-09",
    "ADT": "2021-04-08",
    "ADY": 212,
    "AGE": 44,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0021",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 36.89,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-09-09",
    "ADT": "2023-10-07",
    "ADY": 1124,
    "AGE": 44,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0022",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 22.14,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-11-27",
    "ADT": "2023-10-02",
    "ADY": 675,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0022",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.88,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-11-27",
    "ADT": "2022-04-25",
    "ADY": 150,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0023",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 19.94,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-02-02",
    "ADT": "2023-10-02",
    "ADY": 608,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0023",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 13.53,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2022-02-02",
    "ADT": "2023-03-21",
    "ADY": 413,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0024",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 9.88,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-07-07",
    "ADT": "2021-05-04",
    "ADY": 302,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0024",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 18.16,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-07-07",
    "ADT": "2022-01-11",
    "ADY": 554,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0025",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 19.22,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-02-25",
    "ADT": "2023-10-03",
    "ADY": 586,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0025",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 19.22,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-02-25",
    "ADT": "2023-10-03",
    "ADY": 586,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0026",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 26.05,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-07-30",
    "ADT": "2023-10-01",
    "ADY": 794,
    "AGE": 78,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0026",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 26.05,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-07-30",
    "ADT": "2023-10-01",
    "ADY": 794,
    "AGE": 78,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0027",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 16.31,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-12-23",
    "ADT": "2023-05-03",
    "ADY": 497,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0027",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.56,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-12-23",
    "ADT": "2022-03-11",
    "ADY": 79,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0028",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 22.47,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-05-28",
    "ADT": "2023-04-12",
    "ADY": 685,
    "AGE": 81,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0012-0028",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 28.22,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-05-28",
    "ADT": "2023-10-04",
    "ADY": 860,
    "AGE": 81,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0013-0001",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 8.91,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-12-23",
    "ADT": "2022-09-20",
    "ADY": 272,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0013-0001",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 21.32,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-12-23",
    "ADT": "2023-10-03",
    "ADY": 650,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0013-0002",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 6.78,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-03-29",
    "ADT": "2020-10-21",
    "ADY": 207,
    "AGE": 76,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0013-0002",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 8.22,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-03-29",
    "ADT": "2020-12-04",
    "ADY": 251,
    "AGE": 76,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0013-0003",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 4.75,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-06-26",
    "ADT": "2021-11-18",
    "ADY": 146,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0013-0003",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 0.64,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-06-26",
    "ADT": "2021-07-15",
    "ADY": 20,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0013-0004",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 10.91,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-09-01",
    "ADT": "2021-07-30",
    "ADY": 333,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0013-0004",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 15.15,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-09-01",
    "ADT": "2021-12-06",
    "ADY": 462,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0013-0005",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 11.74,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-07-17",
    "ADT": "2022-07-09",
    "ADY": 358,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0013-0005",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 26.64,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-07-17",
    "ADT": "2023-10-06",
    "ADY": 812,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0013-0006",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 0.2,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-12-31",
    "ADT": "2021-01-06",
    "ADY": 7,
    "AGE": 71,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0013-0006",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 8.23,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-12-31",
    "ADT": "2021-09-08",
    "ADY": 252,
    "AGE": 71,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0013-0007",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 29.63,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-04-18",
    "ADT": "2023-10-07",
    "ADY": 903,
    "AGE": 49,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0013-0007",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 29.63,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-04-18",
    "ADT": "2023-10-07",
    "ADY": 903,
    "AGE": 49,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0013-0008",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 23.66,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-08-11",
    "ADT": "2022-08-01",
    "ADY": 721,
    "AGE": 86,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0013-0008",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 11.81,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-08-11",
    "ADT": "2021-08-05",
    "ADY": 360,
    "AGE": 86,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0013-0009",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.09,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-03-13",
    "ADT": "2020-10-15",
    "ADY": 217,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0013-0009",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 42.64,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-03-13",
    "ADT": "2023-10-02",
    "ADY": 1299,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0013-0010",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 19.28,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-01-13",
    "ADT": "2022-08-23",
    "ADY": 588,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0013-0010",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 32.59,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-01-13",
    "ADT": "2023-10-02",
    "ADY": 993,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0013-0011",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 12.94,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-06-20",
    "ADT": "2021-07-19",
    "ADY": 395,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0013-0011",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 25.31,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-06-20",
    "ADT": "2022-07-30",
    "ADY": 771,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0013-0012",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 20.57,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-01-13",
    "ADT": "2023-10-01",
    "ADY": 627,
    "AGE": 81,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0013-0012",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 14.56,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2022-01-13",
    "ADT": "2023-04-01",
    "ADY": 444,
    "AGE": 81,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0013-0013",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 22.6,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-11-17",
    "ADT": "2023-10-06",
    "ADY": 689,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0013-0013",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 22.6,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-11-17",
    "ADT": "2023-10-06",
    "ADY": 689,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0013-0014",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 15.8,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-07-13",
    "ADT": "2021-11-06",
    "ADY": 482,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0013-0014",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 19.27,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-07-13",
    "ADT": "2022-02-20",
    "ADY": 588,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0013-0015",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 5.98,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-07-17",
    "ADT": "2022-01-15",
    "ADY": 183,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0013-0015",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 22.63,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-07-17",
    "ADT": "2023-06-06",
    "ADY": 690,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0013-0016",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 29.63,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-04-12",
    "ADT": "2023-10-01",
    "ADY": 903,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0013-0016",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 29.63,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-04-12",
    "ADT": "2023-10-01",
    "ADY": 903,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0013-0017",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 28.45,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-05-19",
    "ADT": "2023-10-02",
    "ADY": 867,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0013-0017",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 28.45,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-05-19",
    "ADT": "2023-10-02",
    "ADY": 867,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0013-0018",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 0.58,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-06-25",
    "ADT": "2021-07-13",
    "ADY": 19,
    "AGE": 41,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0013-0018",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 0.99,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-06-25",
    "ADT": "2021-07-25",
    "ADY": 31,
    "AGE": 41,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0013-0019",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 11.36,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-07-29",
    "ADT": "2021-07-10",
    "ADY": 347,
    "AGE": 79,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0013-0019",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 12.86,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-07-29",
    "ADT": "2021-08-24",
    "ADY": 392,
    "AGE": 79,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0013-0020",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 27.89,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-03-09",
    "ADT": "2023-07-06",
    "ADY": 850,
    "AGE": 75,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0013-0020",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 22.46,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-03-09",
    "ADT": "2023-01-22",
    "ADY": 685,
    "AGE": 75,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0013-0021",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 15.1,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-09-30",
    "ADT": "2022-01-03",
    "ADY": 461,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0013-0021",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 27.16,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-09-30",
    "ADT": "2023-01-05",
    "ADY": 828,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0014-0001",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 24.95,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-01-30",
    "ADT": "2023-02-28",
    "ADY": 760,
    "AGE": 56,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0014-0001",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 21.95,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-01-30",
    "ADT": "2022-11-29",
    "ADY": 669,
    "AGE": 56,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0014-0002",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.07,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-11-11",
    "ADT": "2021-01-13",
    "ADY": 64,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0014-0002",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 23.54,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-11-11",
    "ADT": "2022-10-29",
    "ADY": 718,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0014-0003",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 26.03,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-05-25",
    "ADT": "2023-07-26",
    "ADY": 793,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0014-0003",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 28.22,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-05-25",
    "ADT": "2023-10-01",
    "ADY": 860,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0014-0004",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 23.03,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-11-04",
    "ADT": "2023-10-06",
    "ADY": 702,
    "AGE": 79,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0014-0004",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 23.03,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-11-04",
    "ADT": "2023-10-06",
    "ADY": 702,
    "AGE": 79,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0014-0005",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 10.9,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-11-09",
    "ADT": "2022-10-07",
    "ADY": 333,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0014-0005",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 18.55,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-11-09",
    "ADT": "2023-05-28",
    "ADY": 566,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0014-0006",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 21.45,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-12-18",
    "ADT": "2023-10-02",
    "ADY": 654,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0014-0006",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 21.45,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-12-18",
    "ADT": "2023-10-02",
    "ADY": 654,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0014-0007",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 1.69,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-02-16",
    "ADT": "2021-04-08",
    "ADY": 52,
    "AGE": 74,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0014-0007",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 5.49,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-02-16",
    "ADT": "2021-08-02",
    "ADY": 168,
    "AGE": 74,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0014-0008",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 16.6,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-01-31",
    "ADT": "2022-06-20",
    "ADY": 506,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0014-0008",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 26.28,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-01-31",
    "ADT": "2023-04-11",
    "ADY": 801,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0014-0009",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 11.54,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-01-03",
    "ADT": "2021-12-20",
    "ADY": 352,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0014-0009",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 32.94,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-01-03",
    "ADT": "2023-10-03",
    "ADY": 1004,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0014-0010",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.23,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-02-27",
    "ADT": "2021-10-05",
    "ADY": 221,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0014-0010",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 26.53,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-02-27",
    "ADT": "2023-05-16",
    "ADY": 809,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0014-0011",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-01-07",
    "ADT": "2021-05-09",
    "ADY": 123,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0014-0011",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 13.3,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-01-07",
    "ADT": "2022-02-16",
    "ADY": 406,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0014-0012",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 9.31,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-06-14",
    "ADT": "2022-03-24",
    "ADY": 284,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0014-0012",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 14.74,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-06-14",
    "ADT": "2022-09-06",
    "ADY": 450,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0014-0013",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 5.82,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-11-23",
    "ADT": "2022-05-19",
    "ADY": 178,
    "AGE": 74,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0014-0013",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 10.89,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-11-23",
    "ADT": "2022-10-20",
    "ADY": 332,
    "AGE": 74,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0014-0014",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 19.54,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-05-07",
    "ADT": "2022-12-23",
    "ADY": 596,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0014-0014",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 8.51,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-05-07",
    "ADT": "2022-01-21",
    "ADY": 260,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0014-0015",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 1.62,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-11-30",
    "ADT": "2022-01-18",
    "ADY": 50,
    "AGE": 77,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0014-0015",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 4.18,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-11-30",
    "ADT": "2022-04-06",
    "ADY": 128,
    "AGE": 77,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0014-0016",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 10.5,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-08-14",
    "ADT": "2021-06-30",
    "ADY": 321,
    "AGE": 79,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0014-0016",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 16.15,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-08-14",
    "ADT": "2021-12-19",
    "ADY": 493,
    "AGE": 79,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0014-0017",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 26.05,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-08-01",
    "ADT": "2023-10-03",
    "ADY": 794,
    "AGE": 74,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0014-0017",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 26.05,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-08-01",
    "ADT": "2023-10-03",
    "ADY": 794,
    "AGE": 74,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0014-0018",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 3.27,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-06-03",
    "ADT": "2020-09-11",
    "ADY": 101,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0014-0018",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 13.21,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-06-03",
    "ADT": "2021-07-10",
    "ADY": 403,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0014-0019",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.04,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-11-30",
    "ADT": "2021-01-31",
    "ADY": 63,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0014-0019",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 14.6,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-11-30",
    "ADT": "2022-02-17",
    "ADY": 445,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0014-0020",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 23.23,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-10-27",
    "ADT": "2023-10-04",
    "ADY": 708,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0014-0020",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 23.23,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-10-27",
    "ADT": "2023-10-04",
    "ADY": 708,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0014-0021",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 1.31,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-05-22",
    "ADT": "2021-07-01",
    "ADY": 41,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0014-0021",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 28.32,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-05-22",
    "ADT": "2023-10-01",
    "ADY": 863,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0001",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 33.34,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-07-01",
    "ADT": "2023-04-12",
    "ADY": 1016,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0001",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 38.99,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-07-01",
    "ADT": "2023-10-01",
    "ADY": 1188,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0002",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.33,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-08-16",
    "ADT": "2021-03-27",
    "ADY": 224,
    "AGE": 62,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0002",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 17.56,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-08-16",
    "ADT": "2022-02-02",
    "ADY": 536,
    "AGE": 62,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0003",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 42.97,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-03-03",
    "ADT": "2023-10-02",
    "ADY": 1309,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0003",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 42.97,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-03-03",
    "ADT": "2023-10-02",
    "ADY": 1309,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0004",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.83,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-07-10",
    "ADT": "2020-12-04",
    "ADY": 148,
    "AGE": 83,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0004",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 8.74,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-07-10",
    "ADT": "2021-04-02",
    "ADY": 267,
    "AGE": 83,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0005",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 37.06,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-09-02",
    "ADT": "2023-10-05",
    "ADY": 1129,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0005",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 37.06,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-09-02",
    "ADT": "2023-10-05",
    "ADY": 1129,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0006",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 24.26,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-02-28",
    "ADT": "2023-03-08",
    "ADY": 739,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0006",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 22.61,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-02-28",
    "ADT": "2023-01-17",
    "ADY": 689,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0007",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.6,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-11-12",
    "ADT": "2022-07-01",
    "ADY": 232,
    "AGE": 82,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0007",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 22.7,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-11-12",
    "ADT": "2023-10-04",
    "ADY": 692,
    "AGE": 82,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0008",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 1.72,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-03-20",
    "ADT": "2021-05-11",
    "ADY": 53,
    "AGE": 70,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0008",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 2.32,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-03-20",
    "ADT": "2021-05-30",
    "ADY": 72,
    "AGE": 70,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0009",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 14.32,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-12-21",
    "ADT": "2022-03-02",
    "ADY": 437,
    "AGE": 74,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0009",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 33.31,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-12-21",
    "ADT": "2023-10-01",
    "ADY": 1015,
    "AGE": 74,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0010",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 5.26,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-02-07",
    "ADT": "2021-07-17",
    "ADY": 161,
    "AGE": 46,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0010",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 31.87,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-02-07",
    "ADT": "2023-10-05",
    "ADY": 971,
    "AGE": 46,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0011",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 14.06,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-08-25",
    "ADT": "2021-10-27",
    "ADY": 429,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0011",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 23.24,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-08-25",
    "ADT": "2022-08-02",
    "ADY": 708,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0012",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.29,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2022-02-26",
    "ADT": "2022-10-06",
    "ADY": 223,
    "AGE": 82,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0012",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 9.02,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2022-02-26",
    "ADT": "2022-11-28",
    "ADY": 276,
    "AGE": 82,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0013",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.05,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-10-28",
    "ADT": "2022-02-28",
    "ADY": 124,
    "AGE": 76,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0013",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 4.83,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-10-28",
    "ADT": "2022-03-24",
    "ADY": 148,
    "AGE": 76,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0014",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 9.51,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-06-30",
    "ADT": "2022-04-15",
    "ADY": 290,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0014",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 19.87,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-06-30",
    "ADT": "2023-02-25",
    "ADY": 606,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0015",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.6,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-03-14",
    "ADT": "2020-08-01",
    "ADY": 141,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0015",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 5.35,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-03-14",
    "ADT": "2020-08-24",
    "ADY": 164,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0016",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 11.17,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-11-10",
    "ADT": "2021-10-16",
    "ADY": 341,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0016",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 15.57,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-11-10",
    "ADT": "2022-02-27",
    "ADY": 475,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0017",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.66,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-08-31",
    "ADT": "2020-11-20",
    "ADY": 82,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0017",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 3.1,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-08-31",
    "ADT": "2020-12-03",
    "ADY": 95,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0018",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 21.63,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-08-11",
    "ADT": "2022-05-31",
    "ADY": 659,
    "AGE": 71,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0018",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 37.71,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-08-11",
    "ADT": "2023-10-03",
    "ADY": 1149,
    "AGE": 71,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0019",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 23.59,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-10-17",
    "ADT": "2023-10-05",
    "ADY": 719,
    "AGE": 78,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0019",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 23.59,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-10-17",
    "ADT": "2023-10-05",
    "ADY": 719,
    "AGE": 78,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0020",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 5.73,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-05-27",
    "ADT": "2021-11-17",
    "ADY": 175,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0020",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 21.26,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-05-27",
    "ADT": "2023-03-05",
    "ADY": 648,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0021",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 8.34,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-09-15",
    "ADT": "2022-05-27",
    "ADY": 255,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0021",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 24.51,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-09-15",
    "ADT": "2023-10-01",
    "ADY": 747,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0022",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 9.18,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2022-01-12",
    "ADT": "2022-10-18",
    "ADY": 280,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0022",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.17,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2022-01-12",
    "ADT": "2022-05-19",
    "ADY": 128,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0023",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 25.45,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-04-03",
    "ADT": "2023-05-18",
    "ADY": 776,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0023",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 18.53,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-04-03",
    "ADT": "2022-10-19",
    "ADY": 565,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0024",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 27.68,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-10-13",
    "ADT": "2023-02-03",
    "ADY": 844,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0024",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 24.82,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-10-13",
    "ADT": "2022-11-08",
    "ADY": 757,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0025",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 11.08,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-04-20",
    "ADT": "2022-03-23",
    "ADY": 338,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0025",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 6.74,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-04-20",
    "ADT": "2021-11-11",
    "ADY": 206,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0026",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 19.96,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-01-13",
    "ADT": "2022-09-13",
    "ADY": 609,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0026",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 0.28,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-01-13",
    "ADT": "2021-01-22",
    "ADY": 10,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0027",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 18.46,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2022-02-15",
    "ADT": "2023-08-31",
    "ADY": 563,
    "AGE": 80,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0027",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 16.7,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2022-02-15",
    "ADT": "2023-07-08",
    "ADY": 509,
    "AGE": 80,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0028",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 15.82,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-10-27",
    "ADT": "2022-02-21",
    "ADY": 483,
    "AGE": 71,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0028",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 14.7,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-10-27",
    "ADT": "2022-01-17",
    "ADY": 448,
    "AGE": 71,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0029",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 27.43,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-06-24",
    "ADT": "2023-10-07",
    "ADY": 836,
    "AGE": 75,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0029",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 27.43,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-06-24",
    "ADT": "2023-10-07",
    "ADY": 836,
    "AGE": 75,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0030",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 20.63,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-01-16",
    "ADT": "2023-10-06",
    "ADY": 629,
    "AGE": 77,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0015-0030",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 6.56,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2022-01-16",
    "ADT": "2022-08-04",
    "ADY": 201,
    "AGE": 77,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0001",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 42.08,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-03-30",
    "ADT": "2023-10-02",
    "ADY": 1282,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0001",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 9.7,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-03-30",
    "ADT": "2021-01-19",
    "ADY": 296,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0002",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 12.53,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2022-01-06",
    "ADT": "2023-01-22",
    "ADY": 382,
    "AGE": 76,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0002",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 6.64,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2022-01-06",
    "ADT": "2022-07-27",
    "ADY": 203,
    "AGE": 76,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0003",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 17.66,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-09-11",
    "ADT": "2022-03-03",
    "ADY": 539,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0003",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.08,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-09-11",
    "ADT": "2021-04-15",
    "ADY": 217,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0004",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 1.58,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-01-03",
    "ADT": "2021-02-20",
    "ADY": 49,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0004",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 12.3,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-01-03",
    "ADT": "2022-01-12",
    "ADY": 375,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0005",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 2.84,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-11-03",
    "ADT": "2021-01-28",
    "ADY": 87,
    "AGE": 45,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0005",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.63,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-11-03",
    "ADT": "2021-01-22",
    "ADY": 81,
    "AGE": 45,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0006",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 29.4,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-04-22",
    "ADT": "2023-10-04",
    "ADY": 896,
    "AGE": 90,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0006",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 25.39,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-04-22",
    "ADT": "2023-06-04",
    "ADY": 774,
    "AGE": 90,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0007",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 20.95,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-05-18",
    "ADT": "2023-02-15",
    "ADY": 639,
    "AGE": 82,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0007",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 10.56,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-05-18",
    "ADT": "2022-04-04",
    "ADY": 322,
    "AGE": 82,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0008",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 30.68,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-03-16",
    "ADT": "2023-10-06",
    "ADY": 935,
    "AGE": 51,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0008",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 20.65,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-03-16",
    "ADT": "2022-12-05",
    "ADY": 630,
    "AGE": 51,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0009",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 11.98,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-08-23",
    "ADT": "2021-08-23",
    "ADY": 366,
    "AGE": 54,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0009",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 8.37,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-08-23",
    "ADT": "2021-05-05",
    "ADY": 256,
    "AGE": 54,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0010",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 23.36,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-06-22",
    "ADT": "2022-06-03",
    "ADY": 712,
    "AGE": 81,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0010",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 5.1,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-06-22",
    "ADT": "2020-11-24",
    "ADY": 156,
    "AGE": 81,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0011",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 26.16,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-06-16",
    "ADT": "2022-08-21",
    "ADY": 797,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0011",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 10.29,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-06-16",
    "ADT": "2021-04-25",
    "ADY": 314,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0012",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 19.3,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-04-29",
    "ADT": "2021-12-07",
    "ADY": 588,
    "AGE": 78,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0012",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.82,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-04-29",
    "ADT": "2020-09-23",
    "ADY": 148,
    "AGE": 78,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0013",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 24.08,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-10-04",
    "ADT": "2023-10-07",
    "ADY": 734,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0013",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 17.46,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-10-04",
    "ADT": "2023-03-19",
    "ADY": 532,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0014",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 25.72,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-08-15",
    "ADT": "2023-10-07",
    "ADY": 784,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0014",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 25.72,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-08-15",
    "ADT": "2023-10-07",
    "ADY": 784,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0015",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 23.07,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-08-05",
    "ADT": "2023-07-08",
    "ADY": 703,
    "AGE": 71,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0015",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 1.56,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-08-05",
    "ADT": "2021-09-21",
    "ADY": 48,
    "AGE": 71,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0016",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 7.31,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-02-20",
    "ADT": "2021-10-01",
    "ADY": 224,
    "AGE": 84,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0016",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 3.52,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-02-20",
    "ADT": "2021-06-07",
    "ADY": 108,
    "AGE": 84,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0017",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.8,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-11-08",
    "ADT": "2022-02-01",
    "ADY": 86,
    "AGE": 77,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0017",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 22.8,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-11-08",
    "ADT": "2023-10-03",
    "ADY": 695,
    "AGE": 77,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0018",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 10.92,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-06-13",
    "ADT": "2021-05-11",
    "ADY": 333,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0018",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 8.02,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-06-13",
    "ADT": "2021-02-12",
    "ADY": 245,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0019",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 20.8,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-01-06",
    "ADT": "2023-10-01",
    "ADY": 634,
    "AGE": 89,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0019",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 6.72,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2022-01-06",
    "ADT": "2022-07-30",
    "ADY": 206,
    "AGE": 89,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0020",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 4.92,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-11-29",
    "ADT": "2022-04-28",
    "ADY": 151,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0020",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.78,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-11-29",
    "ADT": "2022-02-22",
    "ADY": 86,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0021",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 13.92,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2022-02-01",
    "ADT": "2023-04-01",
    "ADY": 425,
    "AGE": 62,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0021",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.45,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2022-02-01",
    "ADT": "2022-06-16",
    "ADY": 136,
    "AGE": 62,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0022",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 22.59,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-09-02",
    "ADT": "2023-07-22",
    "ADY": 689,
    "AGE": 76,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0022",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 5.44,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-09-02",
    "ADT": "2022-02-15",
    "ADY": 167,
    "AGE": 76,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0023",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 17.1,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-03-27",
    "ADT": "2022-08-30",
    "ADY": 522,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0023",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 0.52,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-03-27",
    "ADT": "2021-04-12",
    "ADY": 17,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0024",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 30.72,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-03-14",
    "ADT": "2023-10-05",
    "ADY": 936,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0024",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 30.72,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-03-14",
    "ADT": "2023-10-05",
    "ADY": 936,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0025",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 17,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-12-29",
    "ADT": "2023-05-30",
    "ADY": 518,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0025",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 11.65,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-12-29",
    "ADT": "2022-12-19",
    "ADY": 356,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0026",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 36.01,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-10-02",
    "ADT": "2023-10-03",
    "ADY": 1097,
    "AGE": 52,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0026",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 36.01,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-10-02",
    "ADT": "2023-10-03",
    "ADY": 1097,
    "AGE": 52,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0027",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 16.46,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-12-22",
    "ADT": "2022-05-07",
    "ADY": 502,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0027",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 1.98,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-12-22",
    "ADT": "2021-02-20",
    "ADY": 61,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0028",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 41.29,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-04-28",
    "ADT": "2023-10-07",
    "ADY": 1258,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0028",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 24.57,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-04-28",
    "ADT": "2022-05-16",
    "ADY": 749,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0029",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 24.11,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-09-27",
    "ADT": "2023-10-01",
    "ADY": 735,
    "AGE": 81,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0029",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 14.61,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-09-27",
    "ADT": "2022-12-16",
    "ADY": 446,
    "AGE": 81,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0030",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 3.62,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2022-01-18",
    "ADT": "2022-05-08",
    "ADY": 111,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0030",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 15.33,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2022-01-18",
    "ADT": "2023-04-30",
    "ADY": 468,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0031",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.43,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2022-01-17",
    "ADT": "2022-06-01",
    "ADY": 136,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0016-0031",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 20.43,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-01-17",
    "ADT": "2023-10-01",
    "ADY": 623,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0017-0001",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 18.07,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-11-28",
    "ADT": "2022-06-01",
    "ADY": 551,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0017-0001",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.62,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-11-28",
    "ADT": "2021-07-18",
    "ADY": 233,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0017-0002",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 36.71,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-08-24",
    "ADT": "2023-09-15",
    "ADY": 1118,
    "AGE": 80,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0017-0002",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 20.39,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-08-24",
    "ADT": "2022-05-07",
    "ADY": 622,
    "AGE": 80,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0017-0003",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 41,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-05-04",
    "ADT": "2023-10-04",
    "ADY": 1249,
    "AGE": 70,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0017-0003",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 41,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-05-04",
    "ADT": "2023-10-04",
    "ADY": 1249,
    "AGE": 70,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0017-0004",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 34.17,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-11-25",
    "ADT": "2023-10-01",
    "ADY": 1041,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0017-0004",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 34.17,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-11-25",
    "ADT": "2023-10-01",
    "ADY": 1041,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0017-0005",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 8.57,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-07-09",
    "ADT": "2022-03-27",
    "ADY": 262,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0017-0005",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 1,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-07-09",
    "ADT": "2021-08-08",
    "ADY": 31,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0017-0006",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 15.7,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-02-13",
    "ADT": "2022-06-06",
    "ADY": 479,
    "AGE": 45,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0017-0006",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 6.53,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-02-13",
    "ADT": "2021-08-31",
    "ADY": 200,
    "AGE": 45,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0017-0007",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 29.71,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-07-13",
    "ADT": "2023-01-03",
    "ADY": 905,
    "AGE": 83,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0017-0007",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.85,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-07-13",
    "ADT": "2020-12-08",
    "ADY": 149,
    "AGE": 83,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0017-0008",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 7.6,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-12-20",
    "ADT": "2021-08-08",
    "ADY": 232,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0017-0008",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.38,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-12-20",
    "ADT": "2021-05-02",
    "ADY": 134,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0017-0009",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 12.82,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-04-26",
    "ADT": "2021-05-21",
    "ADY": 391,
    "AGE": 70,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0017-0009",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 11.55,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-04-26",
    "ADT": "2021-04-13",
    "ADY": 353,
    "AGE": 70,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0017-0010",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 25.79,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-08-07",
    "ADT": "2023-10-01",
    "ADY": 786,
    "AGE": 56,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0017-0010",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 8.18,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-08-07",
    "ADT": "2022-04-13",
    "ADY": 250,
    "AGE": 56,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0017-0011",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 24.24,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-09-23",
    "ADT": "2023-10-01",
    "ADY": 739,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0017-0011",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.05,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-09-23",
    "ADT": "2022-04-26",
    "ADY": 216,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0017-0012",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 27.89,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-06-05",
    "ADT": "2023-10-02",
    "ADY": 850,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0017-0012",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 27.89,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-06-05",
    "ADT": "2023-10-02",
    "ADY": 850,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0017-0013",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 10.64,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-08-03",
    "ADT": "2022-06-23",
    "ADY": 325,
    "AGE": 52,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0017-0013",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 26.02,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-08-03",
    "ADT": "2023-10-04",
    "ADY": 793,
    "AGE": 52,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0017-0014",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 20.53,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-04-10",
    "ADT": "2022-12-26",
    "ADY": 626,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0017-0014",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 18.35,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-04-10",
    "ADT": "2022-10-21",
    "ADY": 560,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0017-0015",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 2.08,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-12-02",
    "ADT": "2021-02-03",
    "ADY": 64,
    "AGE": 45,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0017-0015",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 0.77,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-12-02",
    "ADT": "2020-12-25",
    "ADY": 24,
    "AGE": 45,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0017-0016",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 28.73,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-01-27",
    "ADT": "2023-06-21",
    "ADY": 876,
    "AGE": 76,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0017-0016",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 24.35,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-01-27",
    "ADT": "2023-02-07",
    "ADY": 742,
    "AGE": 76,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0017-0017",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 8.22,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-05-13",
    "ADT": "2022-01-18",
    "ADY": 251,
    "AGE": 74,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0017-0017",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 3.09,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-05-13",
    "ADT": "2021-08-15",
    "ADY": 95,
    "AGE": 74,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0001",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 32.75,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-01-10",
    "ADT": "2023-10-04",
    "ADY": 998,
    "AGE": 50,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0001",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 8.41,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-01-10",
    "ADT": "2021-09-23",
    "ADY": 257,
    "AGE": 50,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0002",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 24.01,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-07-21",
    "ADT": "2022-07-22",
    "ADY": 732,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0002",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 9.36,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-07-21",
    "ADT": "2021-05-02",
    "ADY": 286,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0003",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 22.31,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-04-13",
    "ADT": "2022-02-21",
    "ADY": 680,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0003",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 12.09,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-04-13",
    "ADT": "2021-04-16",
    "ADY": 369,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0004",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 33.77,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-12-08",
    "ADT": "2023-10-02",
    "ADY": 1029,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0004",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 5.48,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-12-08",
    "ADT": "2021-05-24",
    "ADY": 168,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0005",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 23.06,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-10-30",
    "ADT": "2023-10-02",
    "ADY": 703,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0005",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 23.06,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-10-30",
    "ADT": "2023-10-02",
    "ADY": 703,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0006",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 4.09,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-12-31",
    "ADT": "2021-05-04",
    "ADY": 125,
    "AGE": 75,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0006",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 3.3,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-12-31",
    "ADT": "2021-04-10",
    "ADY": 101,
    "AGE": 75,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0007",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 27.16,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-03-12",
    "ADT": "2022-06-17",
    "ADY": 828,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0007",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 13.98,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-03-12",
    "ADT": "2021-05-12",
    "ADY": 427,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0008",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 7.44,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-01-25",
    "ADT": "2021-09-08",
    "ADY": 227,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0008",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 0.95,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-01-25",
    "ADT": "2021-02-23",
    "ADY": 30,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0009",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 10.42,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-07-24",
    "ADT": "2021-06-06",
    "ADY": 318,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0009",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 30.15,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-07-24",
    "ADT": "2023-01-28",
    "ADY": 919,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0010",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 13.56,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-07-16",
    "ADT": "2021-09-02",
    "ADY": 414,
    "AGE": 70,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0010",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.06,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-07-16",
    "ADT": "2020-09-17",
    "ADY": 64,
    "AGE": 70,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0011",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 31.73,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-02-12",
    "ADT": "2023-10-06",
    "ADY": 967,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0011",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 0.74,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-02-12",
    "ADT": "2021-03-07",
    "ADY": 24,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0012",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 34.92,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-11-08",
    "ADT": "2023-10-07",
    "ADY": 1064,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0012",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 20.98,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-11-08",
    "ADT": "2022-08-09",
    "ADY": 640,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0013",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 32.16,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-01-27",
    "ADT": "2023-10-03",
    "ADY": 980,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0013",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 16.36,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-01-27",
    "ADT": "2022-06-09",
    "ADY": 499,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0014",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 17.52,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-06-26",
    "ADT": "2021-12-11",
    "ADY": 534,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0014",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 15.09,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-06-26",
    "ADT": "2021-09-28",
    "ADY": 460,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0015",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 35.38,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-10-21",
    "ADT": "2023-10-03",
    "ADY": 1078,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0015",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 14.7,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-10-21",
    "ADT": "2022-01-11",
    "ADY": 448,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0016",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 16.8,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-09-02",
    "ADT": "2023-01-26",
    "ADY": 512,
    "AGE": 56,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0016",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 0.15,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-09-02",
    "ADT": "2021-09-07",
    "ADY": 6,
    "AGE": 56,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0017",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 11.24,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-03-25",
    "ADT": "2021-03-02",
    "ADY": 343,
    "AGE": 49,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0017",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 8.35,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-03-25",
    "ADT": "2020-12-04",
    "ADY": 255,
    "AGE": 49,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0018",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 11.81,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-05-26",
    "ADT": "2022-05-20",
    "ADY": 360,
    "AGE": 76,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0018",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.71,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-05-26",
    "ADT": "2022-01-16",
    "ADY": 236,
    "AGE": 76,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0019",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 27.5,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-06-21",
    "ADT": "2023-10-06",
    "ADY": 838,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0019",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 27.5,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-06-21",
    "ADT": "2023-10-06",
    "ADY": 838,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0020",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 10.23,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-07-10",
    "ADT": "2021-05-17",
    "ADY": 312,
    "AGE": 62,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0020",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 8.26,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-07-10",
    "ADT": "2021-03-18",
    "ADY": 252,
    "AGE": 62,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0021",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 27.6,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-06-19",
    "ADT": "2023-10-07",
    "ADY": 841,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0021",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 18.96,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-06-19",
    "ADT": "2023-01-17",
    "ADY": 578,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0022",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 1.41,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2022-01-23",
    "ADT": "2022-03-07",
    "ADY": 44,
    "AGE": 48,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0022",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 20.34,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-01-23",
    "ADT": "2023-10-04",
    "ADY": 620,
    "AGE": 48,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0023",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 8.06,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-08-22",
    "ADT": "2022-04-24",
    "ADY": 246,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0023",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 22.34,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-08-22",
    "ADT": "2023-07-03",
    "ADY": 681,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0024",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 21.03,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-11-01",
    "ADT": "2023-08-03",
    "ADY": 641,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0024",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.64,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-11-01",
    "ADT": "2022-01-20",
    "ADY": 81,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0025",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 21.26,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-08-20",
    "ADT": "2023-05-29",
    "ADY": 648,
    "AGE": 56,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0025",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 25.53,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-08-20",
    "ADT": "2023-10-06",
    "ADY": 778,
    "AGE": 56,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0026",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 16.47,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-09-30",
    "ADT": "2022-02-13",
    "ADY": 502,
    "AGE": 48,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0026",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 36.1,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-09-30",
    "ADT": "2023-10-04",
    "ADY": 1100,
    "AGE": 48,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0027",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 32.85,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-01-06",
    "ADT": "2023-10-03",
    "ADY": 1001,
    "AGE": 40,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0018-0027",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 32.85,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-01-06",
    "ADT": "2023-10-03",
    "ADY": 1001,
    "AGE": 40,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0001",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 3.74,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-05-05",
    "ADT": "2020-08-27",
    "ADY": 115,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0001",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 27,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-05-05",
    "ADT": "2022-08-05",
    "ADY": 823,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0002",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 1.56,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2022-02-06",
    "ADT": "2022-03-25",
    "ADY": 48,
    "AGE": 90,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0002",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 10,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2022-02-06",
    "ADT": "2022-12-07",
    "ADY": 305,
    "AGE": 90,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0003",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 15.88,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-05-29",
    "ADT": "2021-09-24",
    "ADY": 484,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0003",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 40.08,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-05-29",
    "ADT": "2023-10-01",
    "ADY": 1221,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0004",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 6.05,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-08-24",
    "ADT": "2022-02-24",
    "ADY": 185,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0004",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 25.3,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-08-24",
    "ADT": "2023-10-03",
    "ADY": 771,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0005",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.47,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-04-13",
    "ADT": "2021-11-26",
    "ADY": 228,
    "AGE": 56,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0005",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 22.38,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-04-13",
    "ADT": "2023-02-23",
    "ADY": 682,
    "AGE": 56,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0006",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 11.66,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-10-27",
    "ADT": "2022-10-17",
    "ADY": 356,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0006",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 13.04,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-10-27",
    "ADT": "2022-11-28",
    "ADY": 398,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0007",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 9.68,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-11-22",
    "ADT": "2021-09-13",
    "ADY": 296,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0007",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 34.26,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-11-22",
    "ADT": "2023-10-01",
    "ADY": 1044,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0008",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 11.02,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-12-31",
    "ADT": "2021-12-01",
    "ADY": 336,
    "AGE": 86,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0008",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 23.04,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-12-31",
    "ADT": "2022-12-02",
    "ADY": 702,
    "AGE": 86,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0009",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.59,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-05-10",
    "ADT": "2021-07-28",
    "ADY": 80,
    "AGE": 90,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0009",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 28.75,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-05-10",
    "ADT": "2023-10-02",
    "ADY": 876,
    "AGE": 90,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0010",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 21.88,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-12-08",
    "ADT": "2023-10-05",
    "ADY": 667,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0010",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 21.88,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-12-08",
    "ADT": "2023-10-05",
    "ADY": 667,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0011",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 8.17,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-06-01",
    "ADT": "2021-02-05",
    "ADY": 250,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0011",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 24.94,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-06-01",
    "ADT": "2022-06-30",
    "ADY": 760,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0012",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.62,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-09-29",
    "ADT": "2021-02-17",
    "ADY": 142,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0012",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 36.24,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-09-29",
    "ADT": "2023-10-07",
    "ADY": 1104,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0013",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 3.15,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-03-26",
    "ADT": "2020-06-30",
    "ADY": 97,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0013",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 25.95,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-03-26",
    "ADT": "2022-05-25",
    "ADY": 791,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0014",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 3.12,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-03-24",
    "ADT": "2020-06-27",
    "ADY": 96,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0014",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 3.77,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-03-24",
    "ADT": "2020-07-17",
    "ADY": 116,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0015",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 15.43,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-12-18",
    "ADT": "2023-04-02",
    "ADY": 471,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0015",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 21.52,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-12-18",
    "ADT": "2023-10-04",
    "ADY": 656,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0016",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 10.95,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-03-22",
    "ADT": "2021-02-18",
    "ADY": 334,
    "AGE": 43,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0016",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 12.61,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-03-22",
    "ADT": "2021-04-10",
    "ADY": 385,
    "AGE": 43,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0017",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 5.08,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-08-02",
    "ADT": "2022-01-04",
    "ADY": 156,
    "AGE": 56,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0017",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 26.08,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-08-02",
    "ADT": "2023-10-05",
    "ADY": 795,
    "AGE": 56,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0018",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 9.15,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-12-18",
    "ADT": "2022-09-23",
    "ADY": 280,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0018",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 10.43,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-12-18",
    "ADT": "2022-10-31",
    "ADY": 318,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0019",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 11.62,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-07-01",
    "ADT": "2021-06-20",
    "ADY": 355,
    "AGE": 90,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0019",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 31.6,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-07-01",
    "ADT": "2023-02-18",
    "ADY": 963,
    "AGE": 90,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0020",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 21.91,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-12-08",
    "ADT": "2023-10-06",
    "ADY": 668,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0020",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 21.91,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-12-08",
    "ADT": "2023-10-06",
    "ADY": 668,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0021",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 8.76,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-03-31",
    "ADT": "2021-12-23",
    "ADY": 268,
    "AGE": 51,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0021",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 30.16,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-03-31",
    "ADT": "2023-10-05",
    "ADY": 919,
    "AGE": 51,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0022",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 8.62,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-03-16",
    "ADT": "2020-12-03",
    "ADY": 263,
    "AGE": 79,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0022",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 12.26,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-03-16",
    "ADT": "2021-03-24",
    "ADY": 374,
    "AGE": 79,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0023",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 12.9,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-03-15",
    "ADT": "2021-04-12",
    "ADY": 394,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0023",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 5.57,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-03-15",
    "ADT": "2020-09-01",
    "ADY": 171,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0024",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 16.28,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-11-21",
    "ADT": "2022-04-01",
    "ADY": 497,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0024",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 21.67,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-11-21",
    "ADT": "2022-09-12",
    "ADY": 661,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0025",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 13.89,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-01-13",
    "ADT": "2022-03-12",
    "ADY": 424,
    "AGE": 78,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0025",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 17.07,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-01-13",
    "ADT": "2022-06-17",
    "ADY": 521,
    "AGE": 78,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0026",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 18.01,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2022-02-15",
    "ADT": "2023-08-17",
    "ADY": 549,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0026",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 19.65,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-02-15",
    "ADT": "2023-10-06",
    "ADY": 599,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0027",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 25.23,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-08-30",
    "ADT": "2023-10-07",
    "ADY": 769,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0027",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 25.23,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-08-30",
    "ADT": "2023-10-07",
    "ADY": 769,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0028",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 17.31,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-06-14",
    "ADT": "2022-11-23",
    "ADY": 528,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0019-0028",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 27.76,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-06-14",
    "ADT": "2023-10-07",
    "ADY": 846,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0020-0001",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 21.65,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-09-21",
    "ADT": "2022-07-12",
    "ADY": 660,
    "AGE": 76,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0020-0001",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 36.43,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-09-21",
    "ADT": "2023-10-05",
    "ADY": 1110,
    "AGE": 76,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0020-0002",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 3.29,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-12-19",
    "ADT": "2022-03-29",
    "ADY": 101,
    "AGE": 84,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0020-0002",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 4.91,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-12-19",
    "ADT": "2022-05-17",
    "ADY": 150,
    "AGE": 84,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0020-0003",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 32.28,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-08-20",
    "ADT": "2023-04-30",
    "ADY": 984,
    "AGE": 70,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0020-0003",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 37.45,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-08-20",
    "ADT": "2023-10-04",
    "ADY": 1141,
    "AGE": 70,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0020-0004",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 9.42,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-08-22",
    "ADT": "2022-06-05",
    "ADY": 288,
    "AGE": 71,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0020-0004",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 9.54,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-08-22",
    "ADT": "2022-06-08",
    "ADY": 291,
    "AGE": 71,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0020-0005",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 18.94,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-07-01",
    "ADT": "2022-01-29",
    "ADY": 578,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0020-0005",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 31.85,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-07-01",
    "ADT": "2023-02-26",
    "ADY": 971,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0020-0006",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 20.8,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2022-01-02",
    "ADT": "2023-09-27",
    "ADY": 634,
    "AGE": 54,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0020-0006",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 20.96,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-01-02",
    "ADT": "2023-10-02",
    "ADY": 639,
    "AGE": 54,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0020-0007",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.51,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-11-06",
    "ADT": "2021-03-23",
    "ADY": 138,
    "AGE": 56,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0020-0007",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 10.29,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-11-06",
    "ADT": "2021-09-15",
    "ADY": 314,
    "AGE": 56,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0020-0008",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 39.19,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-06-25",
    "ADT": "2023-10-01",
    "ADY": 1194,
    "AGE": 75,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0020-0008",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 13.33,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-06-25",
    "ADT": "2021-08-05",
    "ADY": 407,
    "AGE": 75,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0020-0009",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 28.86,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-09-11",
    "ADT": "2023-02-06",
    "ADY": 879,
    "AGE": 56,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0020-0009",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 36.66,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-09-11",
    "ADT": "2023-10-02",
    "ADY": 1117,
    "AGE": 56,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0020-0010",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 11.43,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-08-03",
    "ADT": "2021-07-17",
    "ADY": 349,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0020-0010",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.02,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-08-03",
    "ADT": "2021-03-05",
    "ADY": 215,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0020-0011",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 0.35,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-12-04",
    "ADT": "2020-12-15",
    "ADY": 12,
    "AGE": 75,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0020-0011",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 1.59,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-12-04",
    "ADT": "2021-01-21",
    "ADY": 49,
    "AGE": 75,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0020-0012",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 1.78,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-06-19",
    "ADT": "2021-08-12",
    "ADY": 55,
    "AGE": 54,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0020-0012",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 11.13,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-06-19",
    "ADT": "2022-05-24",
    "ADY": 340,
    "AGE": 54,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0020-0013",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.55,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-12-18",
    "ADT": "2021-08-05",
    "ADY": 231,
    "AGE": 75,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0020-0013",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 9.79,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-12-18",
    "ADT": "2021-10-12",
    "ADY": 299,
    "AGE": 75,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0020-0014",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 29.2,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-04-26",
    "ADT": "2023-10-02",
    "ADY": 890,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0020-0014",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 8.76,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-04-26",
    "ADT": "2022-01-18",
    "ADY": 268,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0020-0015",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.15,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-09-13",
    "ADT": "2020-11-17",
    "ADY": 66,
    "AGE": 40,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0020-0015",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 33.57,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-09-13",
    "ADT": "2023-07-02",
    "ADY": 1023,
    "AGE": 40,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0020-0016",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 6.96,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-11-28",
    "ADT": "2021-06-28",
    "ADY": 213,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0020-0016",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 17.69,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-11-28",
    "ADT": "2022-05-20",
    "ADY": 539,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0020-0017",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 11.43,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-09-11",
    "ADT": "2021-08-25",
    "ADY": 349,
    "AGE": 77,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0020-0017",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 36.79,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-09-11",
    "ADT": "2023-10-06",
    "ADY": 1121,
    "AGE": 77,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0020-0018",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 27.27,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-06-29",
    "ADT": "2023-10-07",
    "ADY": 831,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0020-0018",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 27.27,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-06-29",
    "ADT": "2023-10-07",
    "ADY": 831,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0020-0019",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 25.07,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-05-02",
    "ADT": "2023-06-04",
    "ADY": 764,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0020-0019",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 29.07,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-05-02",
    "ADT": "2023-10-04",
    "ADY": 886,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0020-0020",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 21.81,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-12-12",
    "ADT": "2023-10-07",
    "ADY": 665,
    "AGE": 50,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0020-0020",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 21.81,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-12-12",
    "ADT": "2023-10-07",
    "ADY": 665,
    "AGE": 50,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0001",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.85,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2022-01-01",
    "ADT": "2022-03-29",
    "ADY": 88,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0001",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 3.47,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2022-01-01",
    "ADT": "2022-04-17",
    "ADY": 107,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0002",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 27.3,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-06-25",
    "ADT": "2023-10-04",
    "ADY": 832,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0002",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 27.3,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-06-25",
    "ADT": "2023-10-04",
    "ADY": 832,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0003",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 9.11,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-11-14",
    "ADT": "2022-08-18",
    "ADY": 278,
    "AGE": 78,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0003",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 0.73,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-11-14",
    "ADT": "2021-12-06",
    "ADY": 23,
    "AGE": 78,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0004",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 0.6,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2022-01-19",
    "ADT": "2022-02-06",
    "ADY": 19,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0004",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 20.4,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-01-19",
    "ADT": "2023-10-02",
    "ADY": 622,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0005",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 34.49,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-11-21",
    "ADT": "2023-10-07",
    "ADY": 1051,
    "AGE": 52,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0005",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 34.49,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-11-21",
    "ADT": "2023-10-07",
    "ADY": 1051,
    "AGE": 52,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0006",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 0.6,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-03-31",
    "ADT": "2020-04-18",
    "ADY": 19,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0006",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 13.69,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-03-31",
    "ADT": "2021-05-22",
    "ADY": 418,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0007",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 6.14,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-07-05",
    "ADT": "2021-01-08",
    "ADY": 188,
    "AGE": 76,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0007",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.06,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-07-05",
    "ADT": "2020-09-06",
    "ADY": 64,
    "AGE": 76,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0008",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 3.35,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-12-17",
    "ADT": "2022-03-29",
    "ADY": 103,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0008",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 13.13,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-12-17",
    "ADT": "2023-01-21",
    "ADY": 401,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0009",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.36,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-12-12",
    "ADT": "2022-07-24",
    "ADY": 225,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0009",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 11.82,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-12-12",
    "ADT": "2022-12-07",
    "ADY": 361,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0010",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 23.22,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-02-26",
    "ADT": "2023-02-03",
    "ADY": 708,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0010",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 31.31,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-02-26",
    "ADT": "2023-10-07",
    "ADY": 954,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0011",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 27.63,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-06-13",
    "ADT": "2023-10-02",
    "ADY": 842,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0011",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 14.98,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-06-13",
    "ADT": "2022-09-12",
    "ADY": 457,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0012",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 0.3,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-12-01",
    "ADT": "2021-12-10",
    "ADY": 10,
    "AGE": 77,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0012",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 6.82,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-12-01",
    "ADT": "2022-06-27",
    "ADY": 209,
    "AGE": 77,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0013",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 12.09,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-09-25",
    "ADT": "2021-09-28",
    "ADY": 369,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0013",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 15.99,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-09-25",
    "ADT": "2022-01-25",
    "ADY": 488,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0014",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 3.25,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-09-16",
    "ADT": "2021-12-24",
    "ADY": 100,
    "AGE": 71,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0014",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 24.17,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-09-16",
    "ADT": "2023-09-22",
    "ADY": 737,
    "AGE": 71,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0015",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 27.5,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-06-20",
    "ADT": "2023-10-05",
    "ADY": 838,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0015",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 27.5,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-06-20",
    "ADT": "2023-10-05",
    "ADY": 838,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0016",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 23.06,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-10-30",
    "ADT": "2023-10-02",
    "ADY": 703,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0016",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 6.9,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-10-30",
    "ADT": "2022-05-28",
    "ADY": 211,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0017",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.06,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-11-26",
    "ADT": "2021-06-29",
    "ADY": 216,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0017",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 31.93,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-11-26",
    "ADT": "2023-07-26",
    "ADY": 973,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0018",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 5.83,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-06-02",
    "ADT": "2021-11-26",
    "ADY": 178,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0018",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 27.99,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-06-02",
    "ADT": "2023-10-02",
    "ADY": 853,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0019",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.62,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-02-25",
    "ADT": "2021-05-16",
    "ADY": 81,
    "AGE": 77,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0019",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 4.04,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-02-25",
    "ADT": "2021-06-28",
    "ADY": 124,
    "AGE": 77,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0020",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 28.88,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-05-08",
    "ADT": "2023-10-04",
    "ADY": 880,
    "AGE": 70,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0020",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 28.88,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-05-08",
    "ADT": "2023-10-04",
    "ADY": 880,
    "AGE": 70,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0021",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 3.97,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-01-05",
    "ADT": "2021-05-06",
    "ADY": 122,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0021",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 32.95,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-01-05",
    "ADT": "2023-10-05",
    "ADY": 1004,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0022",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 42.87,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-03-09",
    "ADT": "2023-10-05",
    "ADY": 1306,
    "AGE": 77,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0022",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 42.87,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-03-09",
    "ADT": "2023-10-05",
    "ADY": 1306,
    "AGE": 77,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0023",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 25.36,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-11-29",
    "ADT": "2023-01-10",
    "ADY": 773,
    "AGE": 81,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0023",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 34.07,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-11-29",
    "ADT": "2023-10-02",
    "ADY": 1038,
    "AGE": 81,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0024",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 19.6,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-06-13",
    "ADT": "2023-01-31",
    "ADY": 598,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0024",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.57,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-06-13",
    "ADT": "2021-08-30",
    "ADY": 79,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0025",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 12.45,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-08-18",
    "ADT": "2022-09-01",
    "ADY": 380,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0021-0025",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 20.56,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-08-18",
    "ADT": "2023-05-06",
    "ADY": 627,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0022-0001",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 23.92,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-10-06",
    "ADT": "2023-10-04",
    "ADY": 729,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0022-0001",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 23.92,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-10-06",
    "ADT": "2023-10-04",
    "ADY": 729,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0022-0002",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 6.02,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2022-01-25",
    "ADT": "2022-07-27",
    "ADY": 184,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0022-0002",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 14.57,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2022-01-25",
    "ADT": "2023-04-14",
    "ADY": 445,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0022-0003",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 17.47,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-07-11",
    "ADT": "2022-12-25",
    "ADY": 533,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0022-0003",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 8.71,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-07-11",
    "ADT": "2022-04-02",
    "ADY": 266,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0022-0004",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 12.6,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-09-30",
    "ADT": "2022-10-19",
    "ADY": 385,
    "AGE": 71,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0022-0004",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 24.05,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-09-30",
    "ADT": "2023-10-02",
    "ADY": 733,
    "AGE": 71,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0022-0005",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 27.63,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-04-19",
    "ADT": "2023-08-08",
    "ADY": 842,
    "AGE": 74,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0022-0005",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 13.02,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-04-19",
    "ADT": "2022-05-20",
    "ADY": 397,
    "AGE": 74,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0022-0006",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 32.35,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-03-17",
    "ADT": "2022-11-27",
    "ADY": 986,
    "AGE": 70,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0022-0006",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 37.17,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-03-17",
    "ADT": "2023-04-22",
    "ADY": 1132,
    "AGE": 70,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0022-0007",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 41.89,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-04-06",
    "ADT": "2023-10-03",
    "ADY": 1276,
    "AGE": 74,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0022-0007",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 41.89,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-04-06",
    "ADT": "2023-10-03",
    "ADY": 1276,
    "AGE": 74,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0022-0008",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 9.79,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-05-04",
    "ADT": "2022-02-26",
    "ADY": 299,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0022-0008",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 29.04,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-05-04",
    "ADT": "2023-10-05",
    "ADY": 885,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0022-0009",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 28.81,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-05-12",
    "ADT": "2023-10-06",
    "ADY": 878,
    "AGE": 48,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0022-0009",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 10.32,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-05-12",
    "ADT": "2022-03-22",
    "ADY": 315,
    "AGE": 48,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0022-0010",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.76,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-12-09",
    "ADT": "2022-05-03",
    "ADY": 146,
    "AGE": 49,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0022-0010",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 15.99,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-12-09",
    "ADT": "2023-04-10",
    "ADY": 488,
    "AGE": 49,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0022-0011",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 36.96,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-09-07",
    "ADT": "2023-10-07",
    "ADY": 1126,
    "AGE": 83,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0022-0011",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 36.96,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-09-07",
    "ADT": "2023-10-07",
    "ADY": 1126,
    "AGE": 83,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0022-0012",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 6.04,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-06-07",
    "ADT": "2021-12-08",
    "ADY": 185,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0022-0012",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 18.7,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-06-07",
    "ADT": "2022-12-28",
    "ADY": 570,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0022-0013",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 16.4,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-10-19",
    "ADT": "2023-03-02",
    "ADY": 500,
    "AGE": 44,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0022-0013",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 5.83,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-10-19",
    "ADT": "2022-04-14",
    "ADY": 178,
    "AGE": 44,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0022-0014",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 10.25,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-12-06",
    "ADT": "2022-10-14",
    "ADY": 313,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0022-0014",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 17.13,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-12-06",
    "ADT": "2023-05-11",
    "ADY": 522,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0022-0015",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 32.05,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-11-17",
    "ADT": "2023-07-21",
    "ADY": 977,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0022-0015",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 34.53,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-11-17",
    "ADT": "2023-10-04",
    "ADY": 1052,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0022-0016",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 13.7,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-11-20",
    "ADT": "2022-01-11",
    "ADY": 418,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0022-0016",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 33.33,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-11-20",
    "ADT": "2023-09-01",
    "ADY": 1016,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0022-0017",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 15.92,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-07-16",
    "ADT": "2022-11-13",
    "ADY": 486,
    "AGE": 77,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0022-0017",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 9.87,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-07-16",
    "ADT": "2022-05-12",
    "ADY": 301,
    "AGE": 77,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0022-0018",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 7.11,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-01-23",
    "ADT": "2021-08-27",
    "ADY": 217,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0022-0018",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 1.72,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-01-23",
    "ADT": "2021-03-16",
    "ADY": 53,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0022-0019",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 11.67,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-05-10",
    "ADT": "2021-04-30",
    "ADY": 356,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0022-0019",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 27.5,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-05-10",
    "ADT": "2022-08-25",
    "ADY": 838,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0022-0020",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.6,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-05-01",
    "ADT": "2021-09-18",
    "ADY": 141,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0022-0020",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 7.82,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-05-01",
    "ADT": "2021-12-25",
    "ADY": 239,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0022-0021",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 10.65,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-08-09",
    "ADT": "2022-06-29",
    "ADY": 325,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0022-0021",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 25.82,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-08-09",
    "ADT": "2023-10-04",
    "ADY": 787,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0001",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 12.31,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-05-06",
    "ADT": "2022-05-16",
    "ADY": 376,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0001",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 8.17,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-05-06",
    "ADT": "2022-01-10",
    "ADY": 250,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0002",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 5.46,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-09-11",
    "ADT": "2021-02-24",
    "ADY": 167,
    "AGE": 39,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0002",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 25.43,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-09-11",
    "ADT": "2022-10-25",
    "ADY": 775,
    "AGE": 39,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0003",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 1.79,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-01-28",
    "ADT": "2021-03-23",
    "ADY": 55,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0003",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 7.35,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-01-28",
    "ADT": "2021-09-09",
    "ADY": 225,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0004",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 22.04,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-12-03",
    "ADT": "2023-10-05",
    "ADY": 672,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0004",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 22.04,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-12-03",
    "ADT": "2023-10-05",
    "ADY": 672,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0005",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 13.38,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-01-02",
    "ADT": "2022-02-13",
    "ADY": 408,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0005",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 8.27,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-01-02",
    "ADT": "2021-09-11",
    "ADY": 253,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0006",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 24.67,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-09-15",
    "ADT": "2023-10-06",
    "ADY": 752,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0006",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 24.67,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-09-15",
    "ADT": "2023-10-06",
    "ADY": 752,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0007",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 0.61,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-03-12",
    "ADT": "2021-03-31",
    "ADY": 20,
    "AGE": 76,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0007",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 15.06,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-03-12",
    "ADT": "2022-06-13",
    "ADY": 459,
    "AGE": 76,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0008",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 12.98,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-11-09",
    "ADT": "2021-12-09",
    "ADY": 396,
    "AGE": 81,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0008",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 19.55,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-11-09",
    "ADT": "2022-06-27",
    "ADY": 596,
    "AGE": 81,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0009",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 23.55,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-08-13",
    "ADT": "2022-07-31",
    "ADY": 718,
    "AGE": 50,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0009",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 13.76,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-08-13",
    "ADT": "2021-10-06",
    "ADY": 420,
    "AGE": 50,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0010",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 26.35,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-07-25",
    "ADT": "2023-10-05",
    "ADY": 803,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0010",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 26.35,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-07-25",
    "ADT": "2023-10-05",
    "ADY": 803,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0011",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 8.7,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-08-19",
    "ADT": "2022-05-11",
    "ADY": 266,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0011",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 12.52,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-08-19",
    "ADT": "2022-09-04",
    "ADY": 382,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0012",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 14.78,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-04-24",
    "ADT": "2022-07-18",
    "ADY": 451,
    "AGE": 71,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0012",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 29.27,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-04-24",
    "ADT": "2023-10-02",
    "ADY": 892,
    "AGE": 71,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0013",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.16,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-10-25",
    "ADT": "2022-03-01",
    "ADY": 128,
    "AGE": 75,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0013",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 8.97,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-10-25",
    "ADT": "2022-07-25",
    "ADY": 274,
    "AGE": 75,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0014",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 18.34,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-12-04",
    "ADT": "2023-06-15",
    "ADY": 559,
    "AGE": 82,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0014",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 15.54,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-12-04",
    "ADT": "2023-03-22",
    "ADY": 474,
    "AGE": 82,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0015",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.51,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-12-16",
    "ADT": "2021-03-02",
    "ADY": 77,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0015",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 5.68,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-12-16",
    "ADT": "2021-06-07",
    "ADY": 174,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0016",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 17.07,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2022-01-19",
    "ADT": "2023-06-23",
    "ADY": 521,
    "AGE": 44,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0016",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 20.4,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-01-19",
    "ADT": "2023-10-02",
    "ADY": 622,
    "AGE": 44,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0017",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 21.55,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-07-02",
    "ADT": "2022-04-19",
    "ADY": 657,
    "AGE": 90,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0017",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 27.37,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-07-02",
    "ADT": "2022-10-13",
    "ADY": 834,
    "AGE": 90,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0018",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 33.08,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-12-29",
    "ADT": "2023-10-02",
    "ADY": 1008,
    "AGE": 80,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0018",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 11.38,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-12-29",
    "ADT": "2021-12-10",
    "ADY": 347,
    "AGE": 80,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0019",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 23.55,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-10-17",
    "ADT": "2023-10-04",
    "ADY": 718,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0019",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 23.55,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-10-17",
    "ADT": "2023-10-04",
    "ADY": 718,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0020",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 8.23,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-07-06",
    "ADT": "2022-03-14",
    "ADY": 252,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0020",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 26.97,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-07-06",
    "ADT": "2023-10-05",
    "ADY": 822,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0021",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 8.43,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-12-30",
    "ADT": "2022-09-13",
    "ADY": 258,
    "AGE": 75,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0021",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 19.07,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-12-30",
    "ADT": "2023-08-02",
    "ADY": 581,
    "AGE": 75,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0022",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 15.51,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-11-30",
    "ADT": "2022-03-17",
    "ADY": 473,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0022",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 3.04,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-11-30",
    "ADT": "2021-03-03",
    "ADY": 94,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0023",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 6.8,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-03-13",
    "ADT": "2020-10-06",
    "ADY": 208,
    "AGE": 62,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0023",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 12.06,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-03-13",
    "ADT": "2021-03-15",
    "ADY": 368,
    "AGE": 62,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0024",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 26.94,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-10-12",
    "ADT": "2023-01-10",
    "ADY": 821,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0024",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 16.32,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-10-12",
    "ADT": "2022-02-21",
    "ADY": 498,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0025",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 36.54,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-05-15",
    "ADT": "2023-06-01",
    "ADY": 1113,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0025",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 40.67,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-05-15",
    "ADT": "2023-10-05",
    "ADY": 1239,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0026",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 22.52,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-12-22",
    "ADT": "2022-11-08",
    "ADY": 687,
    "AGE": 47,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0026",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 33.38,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-12-22",
    "ADT": "2023-10-04",
    "ADY": 1017,
    "AGE": 47,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0027",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 20.07,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-10-31",
    "ADT": "2022-07-04",
    "ADY": 612,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0027",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 29.24,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-10-31",
    "ADT": "2023-04-09",
    "ADY": 891,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0028",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 5.5,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-01-09",
    "ADT": "2021-06-25",
    "ADY": 168,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0023-0028",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 6.06,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-01-09",
    "ADT": "2021-07-12",
    "ADY": 185,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0024-0001",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 35.81,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-10-10",
    "ADT": "2023-10-05",
    "ADY": 1091,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0024-0001",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 35.81,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-10-10",
    "ADT": "2023-10-05",
    "ADY": 1091,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0024-0002",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 20.63,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-02-13",
    "ADT": "2022-11-03",
    "ADY": 629,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0024-0002",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 31.64,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-02-13",
    "ADT": "2023-10-04",
    "ADY": 964,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0024-0003",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 1.05,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-12-05",
    "ADT": "2022-01-06",
    "ADY": 33,
    "AGE": 71,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0024-0003",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 18.56,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-12-05",
    "ADT": "2023-06-23",
    "ADY": 566,
    "AGE": 71,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0024-0004",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 3.24,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-04-17",
    "ADT": "2020-07-25",
    "ADY": 100,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0024-0004",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 5.8,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-04-17",
    "ADT": "2020-10-11",
    "ADY": 178,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0024-0005",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.3,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2022-02-02",
    "ADT": "2022-04-13",
    "ADY": 71,
    "AGE": 76,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0024-0005",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 4.11,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2022-02-02",
    "ADT": "2022-06-07",
    "ADY": 126,
    "AGE": 76,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0024-0006",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 11.11,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-08-12",
    "ADT": "2022-07-16",
    "ADY": 339,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0024-0006",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 25.79,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-08-12",
    "ADT": "2023-10-06",
    "ADY": 786,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0024-0007",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 3.21,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-08-08",
    "ADT": "2021-11-14",
    "ADY": 99,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0024-0007",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 25.89,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-08-08",
    "ADT": "2023-10-05",
    "ADY": 789,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0024-0008",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.95,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-11-14",
    "ADT": "2022-07-14",
    "ADY": 243,
    "AGE": 71,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0024-0008",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 22.6,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-11-14",
    "ADT": "2023-10-03",
    "ADY": 689,
    "AGE": 71,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0024-0009",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 40.01,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-05-31",
    "ADT": "2023-10-01",
    "ADY": 1219,
    "AGE": 70,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0024-0009",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 40.01,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-05-31",
    "ADT": "2023-10-01",
    "ADY": 1219,
    "AGE": 70,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0024-0010",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 31.31,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-02-25",
    "ADT": "2023-10-06",
    "ADY": 954,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0024-0010",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 31.31,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-02-25",
    "ADT": "2023-10-06",
    "ADY": 954,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0024-0011",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 5.16,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-08-10",
    "ADT": "2021-01-14",
    "ADY": 158,
    "AGE": 56,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0024-0011",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 21.62,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-08-10",
    "ADT": "2022-05-30",
    "ADY": 659,
    "AGE": 56,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0024-0012",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 8.69,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-10-01",
    "ADT": "2021-06-23",
    "ADY": 266,
    "AGE": 46,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0024-0012",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 30.81,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-10-01",
    "ADT": "2023-04-27",
    "ADY": 939,
    "AGE": 46,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0024-0013",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 22.04,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-11-30",
    "ADT": "2023-10-02",
    "ADY": 672,
    "AGE": 70,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0024-0013",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 22.04,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-11-30",
    "ADT": "2023-10-02",
    "ADY": 672,
    "AGE": 70,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0024-0014",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 8.74,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-07-08",
    "ADT": "2021-03-31",
    "ADY": 267,
    "AGE": 77,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0024-0014",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 38.96,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-07-08",
    "ADT": "2023-10-07",
    "ADY": 1187,
    "AGE": 77,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0024-0015",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 22.77,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-04-26",
    "ADT": "2022-03-20",
    "ADY": 694,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0024-0015",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 32.36,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-04-26",
    "ADT": "2023-01-06",
    "ADY": 986,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0024-0016",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 27.37,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-06-21",
    "ADT": "2023-10-02",
    "ADY": 834,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0024-0016",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 27.37,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-06-21",
    "ADT": "2023-10-02",
    "ADY": 834,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0024-0017",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 1.08,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2022-01-03",
    "ADT": "2022-02-05",
    "ADY": 34,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0024-0017",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 16.83,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2022-01-03",
    "ADT": "2023-05-30",
    "ADY": 513,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0001",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 9,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-12-05",
    "ADT": "2022-09-05",
    "ADY": 275,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0001",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 13.05,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-12-05",
    "ADT": "2023-01-06",
    "ADY": 398,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0002",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 12.3,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2022-01-11",
    "ADT": "2023-01-20",
    "ADY": 375,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0002",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 20.76,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-01-11",
    "ADT": "2023-10-05",
    "ADY": 633,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0003",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.69,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-09-15",
    "ADT": "2022-05-07",
    "ADY": 235,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0003",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 24.51,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-09-15",
    "ADT": "2023-10-01",
    "ADY": 747,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0004",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 19.97,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-08-09",
    "ADT": "2022-04-09",
    "ADY": 609,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0004",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 37.02,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-08-09",
    "ADT": "2023-09-10",
    "ADY": 1128,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0005",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 23.46,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-10-22",
    "ADT": "2023-10-06",
    "ADY": 715,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0005",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.79,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-10-22",
    "ADT": "2022-03-17",
    "ADY": 147,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0006",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 3.79,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-07-31",
    "ADT": "2020-11-23",
    "ADY": 116,
    "AGE": 43,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0006",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 38.21,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-07-31",
    "ADT": "2023-10-07",
    "ADY": 1164,
    "AGE": 43,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0007",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 17.46,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-07-06",
    "ADT": "2022-12-19",
    "ADY": 532,
    "AGE": 51,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0007",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 22.06,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-07-06",
    "ADT": "2023-05-09",
    "ADY": 673,
    "AGE": 51,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0008",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 13.44,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-08-31",
    "ADT": "2022-10-14",
    "ADY": 410,
    "AGE": 81,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0008",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 25.03,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-08-31",
    "ADT": "2023-10-02",
    "ADY": 763,
    "AGE": 81,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0009",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 22.96,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-11-04",
    "ADT": "2023-10-04",
    "ADY": 700,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0009",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 22.96,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-11-04",
    "ADT": "2023-10-04",
    "ADY": 700,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0010",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 11.8,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-05-13",
    "ADT": "2021-05-07",
    "ADY": 360,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0010",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 40.8,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-05-13",
    "ADT": "2023-10-07",
    "ADY": 1243,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0011",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.95,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-04-03",
    "ADT": "2021-09-01",
    "ADY": 152,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0011",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 9.81,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-04-03",
    "ADT": "2022-01-27",
    "ADY": 300,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0012",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 12.43,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-11-05",
    "ADT": "2022-11-18",
    "ADY": 379,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0012",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 23,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-11-05",
    "ADT": "2023-10-06",
    "ADY": 701,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0013",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 8.31,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-09-29",
    "ADT": "2021-06-09",
    "ADY": 254,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0013",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 8.52,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-09-29",
    "ADT": "2021-06-15",
    "ADY": 260,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0014",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.67,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-12-15",
    "ADT": "2021-08-05",
    "ADY": 234,
    "AGE": 54,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0014",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 12.48,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-12-15",
    "ADT": "2021-12-30",
    "ADY": 381,
    "AGE": 54,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0015",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 10.52,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-10-12",
    "ADT": "2021-08-28",
    "ADY": 321,
    "AGE": 75,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0015",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 21.6,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-10-12",
    "ADT": "2022-08-01",
    "ADY": 659,
    "AGE": 75,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0016",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.95,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-09-27",
    "ADT": "2022-02-25",
    "ADY": 152,
    "AGE": 71,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0016",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 16.39,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-09-27",
    "ADT": "2023-02-08",
    "ADY": 500,
    "AGE": 71,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0017",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 1.14,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-08-08",
    "ADT": "2020-09-12",
    "ADY": 36,
    "AGE": 81,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0017",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 12.34,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-08-08",
    "ADT": "2021-08-19",
    "ADY": 377,
    "AGE": 81,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0018",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 21.78,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-12-11",
    "ADT": "2023-10-05",
    "ADY": 664,
    "AGE": 71,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0018",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.59,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-12-11",
    "ADT": "2022-04-30",
    "ADY": 141,
    "AGE": 71,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0019",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 19.48,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-02-19",
    "ADT": "2023-10-05",
    "ADY": 594,
    "AGE": 62,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0019",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 19.48,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-02-19",
    "ADT": "2023-10-05",
    "ADY": 594,
    "AGE": 62,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0020",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 3.56,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-12-25",
    "ADT": "2022-04-12",
    "ADY": 109,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0020",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 0.64,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-12-25",
    "ADT": "2022-01-13",
    "ADY": 20,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0021",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 11.11,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-07-20",
    "ADT": "2021-06-23",
    "ADY": 339,
    "AGE": 46,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0021",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 16.56,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-07-20",
    "ADT": "2021-12-06",
    "ADY": 505,
    "AGE": 46,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0022",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 23.92,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-06-24",
    "ADT": "2022-06-22",
    "ADY": 729,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0022",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 25.43,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-06-24",
    "ADT": "2022-08-07",
    "ADY": 775,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0023",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 25.51,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-02-13",
    "ADT": "2023-04-01",
    "ADY": 778,
    "AGE": 75,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0023",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 31.7,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-02-13",
    "ADT": "2023-10-06",
    "ADY": 966,
    "AGE": 75,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0024",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 29.47,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-04-19",
    "ADT": "2023-10-03",
    "ADY": 898,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0024",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 18.97,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-04-19",
    "ADT": "2022-11-17",
    "ADY": 578,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0025",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 6.58,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-12-11",
    "ADT": "2022-06-29",
    "ADY": 201,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0025",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 21.78,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-12-11",
    "ADT": "2023-10-05",
    "ADY": 664,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0026",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 8.24,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-12-12",
    "ADT": "2021-08-20",
    "ADY": 252,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0026",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 10.14,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-12-12",
    "ADT": "2021-10-17",
    "ADY": 310,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0027",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 29.05,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-06-25",
    "ADT": "2022-11-26",
    "ADY": 885,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0025-0027",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 39.26,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-06-25",
    "ADT": "2023-10-03",
    "ADY": 1196,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0001",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 24.22,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-07-31",
    "ADT": "2022-08-07",
    "ADY": 738,
    "AGE": 75,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0001",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 14.32,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-07-31",
    "ADT": "2021-10-10",
    "ADY": 437,
    "AGE": 75,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0002",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 23.49,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-10-19",
    "ADT": "2023-10-04",
    "ADY": 716,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0002",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 23.49,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-10-19",
    "ADT": "2023-10-04",
    "ADY": 716,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0003",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 16.97,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-10-02",
    "ADT": "2023-03-03",
    "ADY": 518,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0003",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 24.05,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-10-02",
    "ADT": "2023-10-04",
    "ADY": 733,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0004",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 0.68,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-03-24",
    "ADT": "2021-04-14",
    "ADY": 22,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0004",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 21.9,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-03-24",
    "ADT": "2023-01-20",
    "ADY": 668,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0005",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 19.55,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-02-13",
    "ADT": "2023-10-01",
    "ADY": 596,
    "AGE": 82,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0005",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 19.55,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-02-13",
    "ADT": "2023-10-01",
    "ADY": 596,
    "AGE": 82,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0006",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 19.16,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-03-09",
    "ADT": "2021-10-13",
    "ADY": 584,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0006",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.16,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-03-09",
    "ADT": "2020-07-14",
    "ADY": 128,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0007",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.4,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2022-02-01",
    "ADT": "2022-09-14",
    "ADY": 226,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0007",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 20.11,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-02-01",
    "ADT": "2023-10-06",
    "ADY": 613,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0008",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 31.54,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-02-19",
    "ADT": "2023-10-07",
    "ADY": 961,
    "AGE": 46,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0008",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 31.54,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-02-19",
    "ADT": "2023-10-07",
    "ADY": 961,
    "AGE": 46,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0009",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 3.24,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-11-04",
    "ADT": "2021-02-11",
    "ADY": 100,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0009",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 15.81,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-11-04",
    "ADT": "2022-02-28",
    "ADY": 482,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0010",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 29.83,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-04-07",
    "ADT": "2023-10-02",
    "ADY": 909,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0010",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 18.56,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-04-07",
    "ADT": "2022-10-24",
    "ADY": 566,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0011",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 20.24,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-01-29",
    "ADT": "2023-10-07",
    "ADY": 617,
    "AGE": 78,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0011",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 20.24,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-01-29",
    "ADT": "2023-10-07",
    "ADY": 617,
    "AGE": 78,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0012",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 19.88,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-02-07",
    "ADT": "2023-10-05",
    "ADY": 606,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0012",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 19.88,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-02-07",
    "ADT": "2023-10-05",
    "ADY": 606,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0013",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.33,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-06-07",
    "ADT": "2021-10-17",
    "ADY": 133,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0013",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 6.97,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-06-07",
    "ADT": "2022-01-05",
    "ADY": 213,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0014",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 21.14,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-04-21",
    "ADT": "2023-01-25",
    "ADY": 645,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0014",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.43,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-04-21",
    "ADT": "2021-07-04",
    "ADY": 75,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0015",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 5.72,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-08-31",
    "ADT": "2022-02-21",
    "ADY": 175,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0015",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 25.2,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-08-31",
    "ADT": "2023-10-07",
    "ADY": 768,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0016",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 11.5,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-02-26",
    "ADT": "2022-02-11",
    "ADY": 351,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0016",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 23.2,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-02-26",
    "ADT": "2023-02-02",
    "ADY": 707,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0017",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.71,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-09-30",
    "ADT": "2021-02-20",
    "ADY": 144,
    "AGE": 74,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0017",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 26.52,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-09-30",
    "ADT": "2022-12-16",
    "ADY": 808,
    "AGE": 74,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0018",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 22.89,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-01-25",
    "ADT": "2022-12-23",
    "ADY": 698,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0018",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 22.14,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-01-25",
    "ADT": "2022-11-30",
    "ADY": 675,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0019",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 34.43,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-11-17",
    "ADT": "2023-10-01",
    "ADY": 1049,
    "AGE": 54,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0019",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 3.69,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-11-17",
    "ADT": "2021-03-09",
    "ADY": 113,
    "AGE": 54,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0020",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 1.63,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2022-02-08",
    "ADT": "2022-03-30",
    "ADY": 51,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0020",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 9.8,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2022-02-08",
    "ADT": "2022-12-03",
    "ADY": 299,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0021",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 8.37,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2022-02-20",
    "ADT": "2022-11-02",
    "ADY": 256,
    "AGE": 62,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0021",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 10.13,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2022-02-20",
    "ADT": "2022-12-25",
    "ADY": 309,
    "AGE": 62,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0022",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 5.43,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-06-12",
    "ADT": "2020-11-24",
    "ADY": 166,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0022",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 13.66,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-06-12",
    "ADT": "2021-08-02",
    "ADY": 417,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0023",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 28.19,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-06-01",
    "ADT": "2023-10-07",
    "ADY": 859,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0023",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.45,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-06-01",
    "ADT": "2021-08-15",
    "ADY": 76,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0024",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.7,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-07-27",
    "ADT": "2020-12-17",
    "ADY": 144,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0024",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 38.3,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-07-27",
    "ADT": "2023-10-06",
    "ADY": 1167,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0025",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.4,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-07-26",
    "ADT": "2022-03-08",
    "ADY": 226,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0025",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 17.52,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-07-26",
    "ADT": "2023-01-10",
    "ADY": 534,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0026",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 12.97,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-11-26",
    "ADT": "2021-12-26",
    "ADY": 396,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0026",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 13.87,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-11-26",
    "ADT": "2022-01-22",
    "ADY": 423,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0027",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 9.17,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-02-06",
    "ADT": "2021-11-12",
    "ADY": 280,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0026-0027",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.68,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-02-06",
    "ADT": "2021-04-29",
    "ADY": 83,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0027-0001",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 33.94,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-12-07",
    "ADT": "2023-10-06",
    "ADY": 1034,
    "AGE": 46,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0027-0001",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 33.94,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-12-07",
    "ADT": "2023-10-06",
    "ADY": 1034,
    "AGE": 46,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0027-0002",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 18.61,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-08-12",
    "ADT": "2022-03-01",
    "ADY": 567,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0027-0002",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 37.68,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-08-12",
    "ADT": "2023-10-03",
    "ADY": 1148,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0027-0003",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 6.29,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-10-30",
    "ADT": "2022-05-09",
    "ADY": 192,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0027-0003",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 7.79,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-10-30",
    "ADT": "2022-06-24",
    "ADY": 238,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0027-0004",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 30.91,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-03-09",
    "ADT": "2023-10-06",
    "ADY": 942,
    "AGE": 54,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0027-0004",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 30.91,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-03-09",
    "ADT": "2023-10-06",
    "ADY": 942,
    "AGE": 54,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0027-0005",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 24.31,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-11-17",
    "ADT": "2022-11-27",
    "ADY": 741,
    "AGE": 50,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0027-0005",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 32.63,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-11-17",
    "ADT": "2023-08-07",
    "ADY": 994,
    "AGE": 50,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0027-0006",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 36.83,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-09-09",
    "ADT": "2023-10-05",
    "ADY": 1122,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0027-0006",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 21.06,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-09-09",
    "ADT": "2022-06-12",
    "ADY": 642,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0027-0007",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 5.9,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-10-17",
    "ADT": "2021-04-15",
    "ADY": 181,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0027-0007",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 5.91,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-10-17",
    "ADT": "2021-04-15",
    "ADY": 181,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0027-0008",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 1.83,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-02-28",
    "ADT": "2021-04-25",
    "ADY": 57,
    "AGE": 80,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0027-0008",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 12.13,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-02-28",
    "ADT": "2022-03-04",
    "ADY": 370,
    "AGE": 80,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0027-0009",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 42.15,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-03-31",
    "ADT": "2023-10-05",
    "ADY": 1284,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0027-0009",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 42.15,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-03-31",
    "ADT": "2023-10-05",
    "ADY": 1284,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0027-0010",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 27.92,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-06-09",
    "ADT": "2023-10-07",
    "ADY": 851,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0027-0010",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.92,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-06-09",
    "ADT": "2021-09-06",
    "ADY": 90,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0027-0011",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 9.73,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-10-15",
    "ADT": "2021-08-07",
    "ADY": 297,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0027-0011",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 35.51,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-10-15",
    "ADT": "2023-10-01",
    "ADY": 1082,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0027-0012",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.91,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-08-31",
    "ADT": "2022-01-27",
    "ADY": 150,
    "AGE": 54,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0027-0012",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 25.2,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-08-31",
    "ADT": "2023-10-07",
    "ADY": 768,
    "AGE": 54,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0027-0013",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 0.5,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-05-01",
    "ADT": "2021-05-16",
    "ADY": 16,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0027-0013",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 3.43,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-05-01",
    "ADT": "2021-08-13",
    "ADY": 105,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0027-0014",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 17.04,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-04-08",
    "ADT": "2021-09-09",
    "ADY": 520,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0027-0014",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 15.43,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-04-08",
    "ADT": "2021-07-22",
    "ADY": 471,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0027-0015",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 27.4,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-06-20",
    "ADT": "2023-10-02",
    "ADY": 835,
    "AGE": 52,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0027-0015",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 27.4,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-06-20",
    "ADT": "2023-10-02",
    "ADY": 835,
    "AGE": 52,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0027-0016",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 5.96,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-12-18",
    "ADT": "2021-06-17",
    "ADY": 182,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0027-0016",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 33.51,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-12-18",
    "ADT": "2023-10-04",
    "ADY": 1021,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0027-0017",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 5.41,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-03-16",
    "ADT": "2020-08-28",
    "ADY": 166,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0027-0017",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 39.85,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-03-16",
    "ADT": "2023-07-12",
    "ADY": 1214,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0027-0018",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 25.11,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-05-12",
    "ADT": "2022-06-15",
    "ADY": 765,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0027-0018",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 12.84,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-05-12",
    "ADT": "2021-06-07",
    "ADY": 392,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0027-0019",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 35.7,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-08-16",
    "ADT": "2023-08-08",
    "ADY": 1088,
    "AGE": 80,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0027-0019",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 14.2,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-08-16",
    "ADT": "2021-10-22",
    "ADY": 433,
    "AGE": 80,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0027-0020",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 19.77,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-01-26",
    "ADT": "2022-09-20",
    "ADY": 603,
    "AGE": 77,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0027-0020",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 32.33,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-01-26",
    "ADT": "2023-10-07",
    "ADY": 985,
    "AGE": 77,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0027-0021",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 21.96,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-04-17",
    "ADT": "2022-02-14",
    "ADY": 669,
    "AGE": 45,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0027-0021",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 41.46,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-04-17",
    "ADT": "2023-10-01",
    "ADY": 1263,
    "AGE": 45,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0027-0022",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.07,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-05-21",
    "ADT": "2020-09-22",
    "ADY": 125,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0027-0022",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 7.66,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-05-21",
    "ADT": "2021-01-09",
    "ADY": 234,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0001",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 19.22,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-02-25",
    "ADT": "2023-10-03",
    "ADY": 586,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0001",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 5.05,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2022-02-25",
    "ADT": "2022-07-29",
    "ADY": 155,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0002",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 34.72,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-11-12",
    "ADT": "2023-10-05",
    "ADY": 1058,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0002",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 34.72,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-11-12",
    "ADT": "2023-10-05",
    "ADY": 1058,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0003",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 0.27,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-08-24",
    "ADT": "2020-09-01",
    "ADY": 9,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0003",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 16.88,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-08-24",
    "ADT": "2022-01-20",
    "ADY": 515,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0004",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 12.53,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-04-21",
    "ADT": "2021-05-07",
    "ADY": 382,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0004",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 17,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-04-21",
    "ADT": "2021-09-20",
    "ADY": 518,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0005",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 24.54,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-05-11",
    "ADT": "2022-05-28",
    "ADY": 748,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0005",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 23.69,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-05-11",
    "ADT": "2022-05-02",
    "ADY": 722,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0006",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 8.3,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-06-12",
    "ADT": "2022-02-20",
    "ADY": 254,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0006",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 13.38,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-06-12",
    "ADT": "2022-07-24",
    "ADY": 408,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0007",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 8.15,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-04-30",
    "ADT": "2021-01-03",
    "ADY": 249,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0007",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 25.44,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-04-30",
    "ADT": "2022-06-13",
    "ADY": 775,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0008",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 20.8,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-01-07",
    "ADT": "2023-10-02",
    "ADY": 634,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0008",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 20.8,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-01-07",
    "ADT": "2023-10-02",
    "ADY": 634,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0009",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 19.58,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-02-12",
    "ADT": "2023-10-01",
    "ADY": 597,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0009",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 19.58,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-02-12",
    "ADT": "2023-10-01",
    "ADY": 597,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0010",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 19.25,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-12-15",
    "ADT": "2022-07-24",
    "ADY": 587,
    "AGE": 51,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0010",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 6.19,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-12-15",
    "ADT": "2021-06-21",
    "ADY": 189,
    "AGE": 51,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0011",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.49,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-11-25",
    "ADT": "2021-07-11",
    "ADY": 229,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0011",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 9.61,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-11-25",
    "ADT": "2021-09-14",
    "ADY": 294,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0012",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 0.96,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-07-27",
    "ADT": "2020-08-25",
    "ADY": 30,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0012",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 24.7,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-07-27",
    "ADT": "2022-08-18",
    "ADY": 753,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0013",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 5.71,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-10-23",
    "ADT": "2021-04-15",
    "ADY": 175,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0013",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 11.37,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-10-23",
    "ADT": "2021-10-04",
    "ADY": 347,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0014",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 37.09,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-09-02",
    "ADT": "2023-10-06",
    "ADY": 1130,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0014",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 37.09,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-09-02",
    "ADT": "2023-10-06",
    "ADY": 1130,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0015",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 5,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-06-24",
    "ADT": "2020-11-23",
    "ADY": 153,
    "AGE": 75,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0015",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 9.04,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-06-24",
    "ADT": "2021-03-26",
    "ADY": 276,
    "AGE": 75,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0016",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 20.4,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2022-01-01",
    "ADT": "2023-09-14",
    "ADY": 622,
    "AGE": 86,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0016",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 20.96,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-01-01",
    "ADT": "2023-10-01",
    "ADY": 639,
    "AGE": 86,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0017",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 33.34,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-12-23",
    "ADT": "2023-10-04",
    "ADY": 1016,
    "AGE": 45,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0017",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 33.34,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-12-23",
    "ADT": "2023-10-04",
    "ADY": 1016,
    "AGE": 45,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0018",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 32.94,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-08-19",
    "ADT": "2023-05-19",
    "ADY": 1004,
    "AGE": 70,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0018",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 13.09,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-08-19",
    "ADT": "2021-09-21",
    "ADY": 399,
    "AGE": 70,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0019",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.43,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-08-27",
    "ADT": "2021-01-09",
    "ADY": 136,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0019",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 25.87,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-08-27",
    "ADT": "2022-10-23",
    "ADY": 788,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0020",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 40.64,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-05-13",
    "ADT": "2023-10-02",
    "ADY": 1238,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0020",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 40.64,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-05-13",
    "ADT": "2023-10-02",
    "ADY": 1238,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0021",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 0.21,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-04-27",
    "ADT": "2020-05-03",
    "ADY": 7,
    "AGE": 47,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0021",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 1.74,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-04-27",
    "ADT": "2020-06-19",
    "ADY": 54,
    "AGE": 47,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0022",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 30.62,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-03-19",
    "ADT": "2023-10-07",
    "ADY": 933,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0022",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 30.62,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-03-19",
    "ADT": "2023-10-07",
    "ADY": 933,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0023",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 8.17,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-02-01",
    "ADT": "2021-10-08",
    "ADY": 250,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0023",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 11.7,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-02-01",
    "ADT": "2022-01-23",
    "ADY": 357,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0024",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 17.02,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-10-31",
    "ADT": "2023-04-02",
    "ADY": 519,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0024",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.01,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-10-31",
    "ADT": "2022-06-01",
    "ADY": 214,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0025",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 38.99,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-07-04",
    "ADT": "2023-10-04",
    "ADY": 1188,
    "AGE": 77,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0025",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 38.99,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-07-04",
    "ADT": "2023-10-04",
    "ADY": 1188,
    "AGE": 77,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0026",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 9.65,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-05-13",
    "ADT": "2022-03-03",
    "ADY": 295,
    "AGE": 70,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0028-0026",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 11.68,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-05-13",
    "ADT": "2022-05-04",
    "ADY": 357,
    "AGE": 70,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0001",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 3.64,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-07-18",
    "ADT": "2021-11-06",
    "ADY": 112,
    "AGE": 77,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0001",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 15.51,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-07-18",
    "ADT": "2022-11-02",
    "ADY": 473,
    "AGE": 77,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0002",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 13.57,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-06-14",
    "ADT": "2022-08-01",
    "ADY": 414,
    "AGE": 71,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0002",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 27.69,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-06-14",
    "ADT": "2023-10-05",
    "ADY": 844,
    "AGE": 71,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0003",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 1.52,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2022-02-05",
    "ADT": "2022-03-23",
    "ADY": 47,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0003",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 19.88,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-02-05",
    "ADT": "2023-10-03",
    "ADY": 606,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0004",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 0.63,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-01-06",
    "ADT": "2021-01-25",
    "ADY": 20,
    "AGE": 62,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0004",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 12.66,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-01-06",
    "ADT": "2022-01-26",
    "ADY": 386,
    "AGE": 62,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0005",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.1,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-10-20",
    "ADT": "2020-12-23",
    "ADY": 65,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0005",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 2.97,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-10-20",
    "ADT": "2021-01-18",
    "ADY": 91,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0006",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 19.51,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-02-20",
    "ADT": "2023-10-07",
    "ADY": 595,
    "AGE": 78,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0006",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 19.51,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-02-20",
    "ADT": "2023-10-07",
    "ADY": 595,
    "AGE": 78,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0007",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 3.27,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-11-02",
    "ADT": "2022-02-10",
    "ADY": 101,
    "AGE": 74,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0007",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 23.13,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-11-02",
    "ADT": "2023-10-07",
    "ADY": 705,
    "AGE": 74,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0008",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 11.98,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2022-02-10",
    "ADT": "2023-02-10",
    "ADY": 366,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0008",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 19.84,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-02-10",
    "ADT": "2023-10-07",
    "ADY": 605,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0009",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 12.65,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-04-25",
    "ADT": "2021-05-15",
    "ADY": 386,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0009",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 28.08,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-04-25",
    "ADT": "2022-08-28",
    "ADY": 856,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0010",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 9.41,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-05-31",
    "ADT": "2021-03-13",
    "ADY": 287,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0010",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 9.57,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-05-31",
    "ADT": "2021-03-18",
    "ADY": 292,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0011",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 30.91,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-03-10",
    "ADT": "2023-10-07",
    "ADY": 942,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0011",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 0.35,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-03-10",
    "ADT": "2021-03-21",
    "ADY": 12,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0012",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 33.34,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-12-22",
    "ADT": "2023-10-03",
    "ADY": 1016,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0012",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 33.34,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-12-22",
    "ADT": "2023-10-03",
    "ADY": 1016,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0013",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.15,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-01-07",
    "ADT": "2021-03-13",
    "ADY": 66,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0013",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 6.04,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-01-07",
    "ADT": "2021-07-10",
    "ADY": 185,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0014",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.03,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-04-08",
    "ADT": "2021-11-08",
    "ADY": 215,
    "AGE": 54,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0014",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 10.85,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-04-08",
    "ADT": "2022-03-04",
    "ADY": 331,
    "AGE": 54,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0015",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 23.82,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-03-27",
    "ADT": "2023-03-22",
    "ADY": 726,
    "AGE": 87,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0015",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 30.35,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-03-27",
    "ADT": "2023-10-07",
    "ADY": 925,
    "AGE": 87,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0016",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 3.31,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-09-18",
    "ADT": "2021-12-28",
    "ADY": 102,
    "AGE": 54,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0016",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 23.45,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-09-18",
    "ADT": "2023-09-02",
    "ADY": 715,
    "AGE": 54,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0017",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.89,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-08-24",
    "ADT": "2021-04-21",
    "ADY": 241,
    "AGE": 77,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0017",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 37.25,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-08-24",
    "ADT": "2023-10-02",
    "ADY": 1135,
    "AGE": 77,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0018",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 16.91,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2022-01-04",
    "ADT": "2023-06-03",
    "ADY": 516,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0018",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 19.85,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2022-01-04",
    "ADT": "2023-08-31",
    "ADY": 605,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0019",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 14.24,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-09-25",
    "ADT": "2021-12-02",
    "ADY": 434,
    "AGE": 56,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0019",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 36.2,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-09-25",
    "ADT": "2023-10-02",
    "ADY": 1103,
    "AGE": 56,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0020",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 19.05,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-02-28",
    "ADT": "2023-10-01",
    "ADY": 581,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0020",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 19.05,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-02-28",
    "ADT": "2023-10-01",
    "ADY": 581,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0021",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.99,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-03-17",
    "ADT": "2021-06-16",
    "ADY": 92,
    "AGE": 70,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0021",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 30.52,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-03-17",
    "ADT": "2023-10-02",
    "ADY": 930,
    "AGE": 70,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0022",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 19.08,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2022-02-01",
    "ADT": "2023-09-05",
    "ADY": 582,
    "AGE": 78,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0022",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 20.01,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-02-01",
    "ADT": "2023-10-03",
    "ADY": 610,
    "AGE": 78,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0023",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 5.63,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-06-27",
    "ADT": "2020-12-15",
    "ADY": 172,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0023",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 39.19,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-06-27",
    "ADT": "2023-10-03",
    "ADY": 1194,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0024",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 18.93,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-07-09",
    "ADT": "2022-02-05",
    "ADY": 577,
    "AGE": 54,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0024",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 16.01,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-07-09",
    "ADT": "2021-11-08",
    "ADY": 488,
    "AGE": 54,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0025",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 11.57,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-02-04",
    "ADT": "2022-01-22",
    "ADY": 353,
    "AGE": 75,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0025",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 31.93,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-02-04",
    "ADT": "2023-10-04",
    "ADY": 973,
    "AGE": 75,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0026",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 3.09,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-12-12",
    "ADT": "2021-03-16",
    "ADY": 95,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0026",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 33.74,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-12-12",
    "ADT": "2023-10-05",
    "ADY": 1028,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0027",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.38,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-05-02",
    "ADT": "2020-07-13",
    "ADY": 73,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0029-0027",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 6.6,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-05-02",
    "ADT": "2020-11-19",
    "ADY": 202,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0030-0001",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 5.68,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-06-14",
    "ADT": "2020-12-04",
    "ADY": 174,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0030-0001",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 8.57,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-06-14",
    "ADT": "2021-03-02",
    "ADY": 262,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0030-0002",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.71,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-10-09",
    "ADT": "2022-03-01",
    "ADY": 144,
    "AGE": 62,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0030-0002",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 7.12,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-10-09",
    "ADT": "2022-05-14",
    "ADY": 218,
    "AGE": 62,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0030-0003",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 3.3,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-02-23",
    "ADT": "2021-06-03",
    "ADY": 101,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0030-0003",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 13.93,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-02-23",
    "ADT": "2022-04-23",
    "ADY": 425,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0030-0004",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 10.92,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-09-28",
    "ADT": "2021-08-26",
    "ADY": 333,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0030-0004",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 36.14,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-09-28",
    "ADT": "2023-10-03",
    "ADY": 1101,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0030-0005",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 11.81,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2022-01-26",
    "ADT": "2023-01-20",
    "ADY": 360,
    "AGE": 45,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0030-0005",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 20.27,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-01-26",
    "ADT": "2023-10-05",
    "ADY": 618,
    "AGE": 45,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0030-0006",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.6,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-06-12",
    "ADT": "2021-01-29",
    "ADY": 232,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0030-0006",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 26.63,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-06-12",
    "ADT": "2022-09-01",
    "ADY": 812,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0030-0007",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 22.3,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-05-20",
    "ADT": "2023-03-30",
    "ADY": 680,
    "AGE": 82,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0030-0007",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 28.42,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-05-20",
    "ADT": "2023-10-02",
    "ADY": 866,
    "AGE": 82,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0030-0008",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 10.74,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-08-29",
    "ADT": "2021-07-22",
    "ADY": 328,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0030-0008",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 22.13,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-08-29",
    "ADT": "2022-07-04",
    "ADY": 675,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0030-0009",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 23.46,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-10-23",
    "ADT": "2023-10-07",
    "ADY": 715,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0030-0009",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 23.46,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-10-23",
    "ADT": "2023-10-07",
    "ADY": 715,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0030-0010",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 31.44,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-10-24",
    "ADT": "2023-06-08",
    "ADY": 958,
    "AGE": 70,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0030-0010",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 21.77,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-10-24",
    "ADT": "2022-08-18",
    "ADY": 664,
    "AGE": 70,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0030-0011",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 17.68,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-07-20",
    "ADT": "2023-01-09",
    "ADY": 539,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0030-0011",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 26.41,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-07-20",
    "ADT": "2023-10-02",
    "ADY": 805,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0030-0012",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 1.88,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-05-13",
    "ADT": "2020-07-09",
    "ADY": 58,
    "AGE": 75,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0030-0012",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 5.6,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-05-13",
    "ADT": "2020-10-30",
    "ADY": 171,
    "AGE": 75,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0030-0013",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 16.44,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-09-05",
    "ADT": "2022-01-18",
    "ADY": 501,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0030-0013",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 6.45,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-09-05",
    "ADT": "2021-03-20",
    "ADY": 197,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0030-0014",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 42.97,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-03-08",
    "ADT": "2023-10-07",
    "ADY": 1309,
    "AGE": 62,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0030-0014",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 30.73,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-03-08",
    "ADT": "2022-09-29",
    "ADY": 936,
    "AGE": 62,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0030-0015",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 10.9,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-05-28",
    "ADT": "2022-04-25",
    "ADY": 333,
    "AGE": 52,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0030-0015",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 5.18,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-05-28",
    "ADT": "2021-11-02",
    "ADY": 159,
    "AGE": 52,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0030-0016",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 18.28,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-06-17",
    "ADT": "2021-12-25",
    "ADY": 557,
    "AGE": 82,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0030-0016",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 15.51,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-06-17",
    "ADT": "2021-10-02",
    "ADY": 473,
    "AGE": 82,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0030-0017",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 14.91,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-08-31",
    "ADT": "2022-11-28",
    "ADY": 455,
    "AGE": 38,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0030-0017",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 12.03,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-08-31",
    "ADT": "2022-09-01",
    "ADY": 367,
    "AGE": 38,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0030-0018",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 15.96,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-08-22",
    "ADT": "2022-12-21",
    "ADY": 487,
    "AGE": 70,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0030-0018",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 9.84,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-08-22",
    "ADT": "2022-06-18",
    "ADY": 301,
    "AGE": 70,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0030-0019",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 26.58,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-07-17",
    "ADT": "2023-10-04",
    "ADY": 810,
    "AGE": 46,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0030-0019",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 0.61,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-07-17",
    "ADT": "2021-08-05",
    "ADY": 20,
    "AGE": 46,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0030-0020",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 26.58,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-07-15",
    "ADT": "2023-10-02",
    "ADY": 810,
    "AGE": 79,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0030-0020",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 18.71,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-07-15",
    "ADT": "2023-02-05",
    "ADY": 571,
    "AGE": 79,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0030-0021",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 35.39,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-08-31",
    "ADT": "2023-08-13",
    "ADY": 1078,
    "AGE": 85,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0030-0021",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 27.1,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-08-31",
    "ADT": "2022-12-04",
    "ADY": 826,
    "AGE": 85,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0001",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 23.62,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-10-18",
    "ADT": "2023-10-07",
    "ADY": 720,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0001",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 23.62,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-10-18",
    "ADT": "2023-10-07",
    "ADY": 720,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0002",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 22.9,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-07-07",
    "ADT": "2022-06-04",
    "ADY": 698,
    "AGE": 87,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0002",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 15.45,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-07-07",
    "ADT": "2021-10-20",
    "ADY": 471,
    "AGE": 87,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0003",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 8.83,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-08-18",
    "ADT": "2022-05-14",
    "ADY": 270,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0003",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.79,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-08-18",
    "ADT": "2021-11-11",
    "ADY": 86,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0004",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 28.58,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-05-14",
    "ADT": "2023-10-01",
    "ADY": 871,
    "AGE": 75,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0004",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 28.58,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-05-14",
    "ADT": "2023-10-01",
    "ADY": 871,
    "AGE": 75,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0005",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 20.42,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-03-27",
    "ADT": "2021-12-09",
    "ADY": 623,
    "AGE": 70,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0005",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 16.31,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-03-27",
    "ADT": "2021-08-05",
    "ADY": 497,
    "AGE": 70,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0006",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 35.18,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-10-29",
    "ADT": "2023-10-05",
    "ADY": 1072,
    "AGE": 52,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0006",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.17,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-10-29",
    "ADT": "2021-03-05",
    "ADY": 128,
    "AGE": 52,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0007",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 4.63,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-06-19",
    "ADT": "2020-11-07",
    "ADY": 142,
    "AGE": 89,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0007",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.6,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-06-19",
    "ADT": "2020-09-06",
    "ADY": 80,
    "AGE": 89,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0008",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 20.62,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2022-01-07",
    "ADT": "2023-09-27",
    "ADY": 629,
    "AGE": 49,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0008",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 3.93,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2022-01-07",
    "ADT": "2022-05-07",
    "ADY": 121,
    "AGE": 49,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0009",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 23.2,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-10-03",
    "ADT": "2022-09-09",
    "ADY": 707,
    "AGE": 52,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0009",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.94,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-10-03",
    "ADT": "2021-03-02",
    "ADY": 151,
    "AGE": 52,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0010",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 29.34,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-04-23",
    "ADT": "2023-10-03",
    "ADY": 894,
    "AGE": 83,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0010",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 29.34,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-04-23",
    "ADT": "2023-10-03",
    "ADY": 894,
    "AGE": 83,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0011",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 21.57,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-10-10",
    "ADT": "2023-07-29",
    "ADY": 658,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0011",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 9.53,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-10-10",
    "ADT": "2022-07-27",
    "ADY": 291,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0012",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 13.08,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-04-28",
    "ADT": "2021-05-31",
    "ADY": 399,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0012",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 3.45,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-04-28",
    "ADT": "2020-08-11",
    "ADY": 106,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0013",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 20.9,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-11-24",
    "ADT": "2023-08-22",
    "ADY": 637,
    "AGE": 75,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0013",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 13.01,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-11-24",
    "ADT": "2022-12-25",
    "ADY": 397,
    "AGE": 75,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0014",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 3.84,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-03-12",
    "ADT": "2020-07-07",
    "ADY": 118,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0014",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 3.8,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-03-12",
    "ADT": "2020-07-06",
    "ADY": 117,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0015",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 12.84,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-07-03",
    "ADT": "2021-07-29",
    "ADY": 392,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0015",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 11.58,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-07-03",
    "ADT": "2021-06-20",
    "ADY": 353,
    "AGE": 66,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0016",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 25.07,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-09-01",
    "ADT": "2023-10-04",
    "ADY": 764,
    "AGE": 78,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0016",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 25.07,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-09-01",
    "ADT": "2023-10-04",
    "ADY": 764,
    "AGE": 78,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0017",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 3.07,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-08-17",
    "ADT": "2021-11-18",
    "ADY": 94,
    "AGE": 86,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0017",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 4.85,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-08-17",
    "ADT": "2022-01-12",
    "ADY": 149,
    "AGE": 86,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0018",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 20.92,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-03-04",
    "ADT": "2022-12-01",
    "ADY": 638,
    "AGE": 81,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0018",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 5.15,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-03-04",
    "ADT": "2021-08-08",
    "ADY": 158,
    "AGE": 81,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0019",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 11.75,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-09-27",
    "ADT": "2022-09-20",
    "ADY": 359,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0019",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 3.46,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-09-27",
    "ADT": "2022-01-10",
    "ADY": 106,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0020",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 11.75,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-03-11",
    "ADT": "2022-03-04",
    "ADY": 359,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0020",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 9.02,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-03-11",
    "ADT": "2021-12-11",
    "ADY": 276,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0021",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 25.62,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-08-12",
    "ADT": "2023-10-01",
    "ADY": 781,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0021",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 11.62,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-08-12",
    "ADT": "2022-08-01",
    "ADY": 355,
    "AGE": 61,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0022",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 24.44,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-09-19",
    "ADT": "2023-10-03",
    "ADY": 745,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0022",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 24.44,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-09-19",
    "ADT": "2023-10-03",
    "ADY": 745,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0023",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 19.8,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-08-28",
    "ADT": "2022-04-23",
    "ADY": 604,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0023",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 11.61,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-08-28",
    "ADT": "2021-08-16",
    "ADY": 354,
    "AGE": 57,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0024",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 3.11,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-08-17",
    "ADT": "2021-11-20",
    "ADY": 96,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0024",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 1.55,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-08-17",
    "ADT": "2021-10-03",
    "ADY": 48,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0025",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 32.42,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-05-03",
    "ADT": "2023-01-15",
    "ADY": 988,
    "AGE": 48,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0025",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.31,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-05-03",
    "ADT": "2020-09-11",
    "ADY": 132,
    "AGE": 48,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0026",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 9.67,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-04-26",
    "ADT": "2021-02-14",
    "ADY": 295,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0026",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 0.31,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-04-26",
    "ADT": "2020-05-05",
    "ADY": 10,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0027",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 24.11,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-09-29",
    "ADT": "2023-10-03",
    "ADY": 735,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0031-0027",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.32,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-09-29",
    "ADT": "2022-05-10",
    "ADY": 224,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0032-0001",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 14.07,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-01-26",
    "ADT": "2022-03-30",
    "ADY": 429,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0032-0001",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.36,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-01-26",
    "ADT": "2021-04-08",
    "ADY": 73,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0032-0002",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 34.07,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-11-30",
    "ADT": "2023-10-03",
    "ADY": 1038,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0032-0002",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 10.89,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-11-30",
    "ADT": "2021-10-27",
    "ADY": 332,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0032-0003",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 5.15,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-11-14",
    "ADT": "2021-04-20",
    "ADY": 158,
    "AGE": 71,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0032-0003",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 14.9,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-11-14",
    "ADT": "2022-02-11",
    "ADY": 455,
    "AGE": 71,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0032-0004",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 3.17,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-04-01",
    "ADT": "2021-07-06",
    "ADY": 97,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0032-0004",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 6.69,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-04-01",
    "ADT": "2021-10-22",
    "ADY": 205,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0032-0005",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 21.42,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-12-18",
    "ADT": "2023-10-01",
    "ADY": 653,
    "AGE": 82,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0032-0005",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.92,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-12-18",
    "ADT": "2022-03-17",
    "ADY": 90,
    "AGE": 82,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0032-0006",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 21.06,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-01-02",
    "ADT": "2023-10-05",
    "ADY": 642,
    "AGE": 76,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0032-0006",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 21.06,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-01-02",
    "ADT": "2023-10-05",
    "ADY": 642,
    "AGE": 76,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0032-0007",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 18.48,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-09-21",
    "ADT": "2022-04-07",
    "ADY": 564,
    "AGE": 78,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0032-0007",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 6.59,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-09-21",
    "ADT": "2021-04-10",
    "ADY": 202,
    "AGE": 78,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0032-0008",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 42.21,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-03-29",
    "ADT": "2023-10-05",
    "ADY": 1286,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0032-0008",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.88,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-03-29",
    "ADT": "2020-06-25",
    "ADY": 89,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0032-0009",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 11.61,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-02-24",
    "ADT": "2022-02-12",
    "ADY": 354,
    "AGE": 74,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0032-0009",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 6.97,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-02-24",
    "ADT": "2021-09-24",
    "ADY": 213,
    "AGE": 74,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0032-0010",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 25.96,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-04-12",
    "ADT": "2022-06-11",
    "ADY": 791,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0032-0010",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 5.46,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-04-12",
    "ADT": "2020-09-25",
    "ADY": 167,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0032-0011",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 21.02,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-01-02",
    "ADT": "2023-10-04",
    "ADY": 641,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0032-0011",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 21.02,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-01-02",
    "ADT": "2023-10-04",
    "ADY": 641,
    "AGE": 53,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0032-0012",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 13.48,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-04-18",
    "ADT": "2022-06-02",
    "ADY": 411,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0032-0012",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 13.36,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-04-18",
    "ADT": "2022-05-30",
    "ADY": 408,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0032-0013",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 33.38,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-12-22",
    "ADT": "2023-10-04",
    "ADY": 1017,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0032-0013",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 9.48,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-12-22",
    "ADT": "2021-10-07",
    "ADY": 290,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0032-0014",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 10.53,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-10-14",
    "ADT": "2022-08-31",
    "ADY": 322,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0032-0014",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 5.93,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-10-14",
    "ADT": "2022-04-13",
    "ADY": 182,
    "AGE": 58,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0032-0015",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 14.54,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-05-19",
    "ADT": "2022-08-05",
    "ADY": 444,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0032-0015",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 12.42,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-05-19",
    "ADT": "2022-06-01",
    "ADY": 379,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0032-0016",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 24.31,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-05-17",
    "ADT": "2022-05-27",
    "ADY": 741,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0032-0016",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.09,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-05-17",
    "ADT": "2020-09-18",
    "ADY": 125,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0032-0017",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.43,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-07-29",
    "ADT": "2020-10-11",
    "ADY": 75,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0032-0017",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 38.24,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-07-29",
    "ADT": "2023-10-06",
    "ADY": 1165,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0032-0018",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 19.16,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-09-26",
    "ADT": "2022-05-02",
    "ADY": 584,
    "AGE": 47,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0032-0018",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 18.55,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-09-26",
    "ADT": "2022-04-14",
    "ADY": 566,
    "AGE": 47,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0032-0019",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 29.14,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-04-30",
    "ADT": "2023-10-04",
    "ADY": 888,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0032-0019",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 29.14,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-04-30",
    "ADT": "2023-10-04",
    "ADY": 888,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0032-0020",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 8.09,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-10-16",
    "ADT": "2022-06-19",
    "ADY": 247,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0032-0020",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 2.08,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-10-16",
    "ADT": "2021-12-18",
    "ADY": 64,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0001",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 21.78,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-08-14",
    "ADT": "2023-06-08",
    "ADY": 664,
    "AGE": 74,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0001",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.86,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-08-14",
    "ADT": "2022-01-09",
    "ADY": 149,
    "AGE": 74,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0002",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 28.42,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-05-24",
    "ADT": "2023-10-06",
    "ADY": 866,
    "AGE": 76,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0002",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 28.42,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-05-24",
    "ADT": "2023-10-06",
    "ADY": 866,
    "AGE": 76,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0003",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 20.6,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-01-18",
    "ADT": "2023-10-07",
    "ADY": 628,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0003",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 20.6,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2022-01-18",
    "ADT": "2023-10-07",
    "ADY": 628,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0004",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 19.6,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-10-14",
    "ADT": "2022-06-03",
    "ADY": 598,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0004",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 15.37,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-10-14",
    "ADT": "2022-01-25",
    "ADY": 469,
    "AGE": 68,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0005",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 31.11,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-03-04",
    "ADT": "2023-10-07",
    "ADY": 948,
    "AGE": 75,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0005",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 16.35,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-03-04",
    "ADT": "2022-07-15",
    "ADY": 499,
    "AGE": 75,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0006",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 31.83,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-02-07",
    "ADT": "2023-10-04",
    "ADY": 970,
    "AGE": 81,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0006",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 13.98,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-02-07",
    "ADT": "2022-04-09",
    "ADY": 427,
    "AGE": 81,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0007",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 15.38,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-11-02",
    "ADT": "2023-02-13",
    "ADY": 469,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0007",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 10.58,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-11-02",
    "ADT": "2022-09-20",
    "ADY": 323,
    "AGE": 63,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0008",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 23.92,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-10-06",
    "ADT": "2023-10-04",
    "ADY": 729,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0008",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 0.51,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-10-06",
    "ADT": "2021-10-22",
    "ADY": 17,
    "AGE": 67,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0009",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 34.26,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-11-22",
    "ADT": "2023-10-01",
    "ADY": 1044,
    "AGE": 62,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0009",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 21.84,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-11-22",
    "ADT": "2022-09-18",
    "ADY": 666,
    "AGE": 62,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0010",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 11.9,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-09-08",
    "ADT": "2021-09-05",
    "ADY": 363,
    "AGE": 52,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0010",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 36.89,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-09-08",
    "ADT": "2023-10-06",
    "ADY": 1124,
    "AGE": 52,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0011",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 21.44,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-12-11",
    "ADT": "2022-09-25",
    "ADY": 654,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0011",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 15.39,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-12-11",
    "ADT": "2022-03-24",
    "ADY": 469,
    "AGE": 60,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0012",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 21.75,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-12-10",
    "ADT": "2023-10-03",
    "ADY": 663,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0012",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 12.05,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-12-10",
    "ADT": "2022-12-12",
    "ADY": 368,
    "AGE": 55,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0013",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 8.23,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-12-03",
    "ADT": "2021-08-11",
    "ADY": 252,
    "AGE": 70,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0013",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 4.26,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-12-03",
    "ADT": "2021-04-12",
    "ADY": 131,
    "AGE": 70,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0014",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 26.81,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-07-08",
    "ADT": "2023-10-02",
    "ADY": 817,
    "AGE": 76,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0014",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 26.81,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-07-08",
    "ADT": "2023-10-02",
    "ADY": 817,
    "AGE": 76,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0015",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 13.16,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-05-17",
    "ADT": "2021-06-22",
    "ADY": 402,
    "AGE": 85,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0015",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 3.48,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-05-17",
    "ADT": "2020-08-31",
    "ADY": 107,
    "AGE": 85,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0016",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 11.92,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-06-08",
    "ADT": "2022-06-06",
    "ADY": 364,
    "AGE": 49,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0016",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 6.69,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-06-08",
    "ADT": "2021-12-29",
    "ADY": 205,
    "AGE": 49,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0017",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 34.59,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-11-15",
    "ADT": "2023-10-04",
    "ADY": 1054,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0017",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 1.44,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-11-15",
    "ADT": "2020-12-29",
    "ADY": 45,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0018",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 25.46,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-08-22",
    "ADT": "2023-10-06",
    "ADY": 776,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0018",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 25.46,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2021-08-22",
    "ADT": "2023-10-06",
    "ADY": 776,
    "AGE": 59,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "dMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0019",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 39.91,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-06-04",
    "ADT": "2023-10-02",
    "ADY": 1216,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0019",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 28.5,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-06-04",
    "ADT": "2022-10-20",
    "ADY": 869,
    "AGE": 72,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0020",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 9.36,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-05-27",
    "ADT": "2022-03-08",
    "ADY": 286,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0020",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 7.1,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-05-27",
    "ADT": "2021-12-29",
    "ADY": 217,
    "AGE": 69,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0021",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 34.79,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-11-10",
    "ADT": "2023-10-05",
    "ADY": 1060,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0021",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 34.79,
    "CNSR": 1,
    "EVNTDESC": "CENSORED",
    "STARTDT": "2020-11-10",
    "ADT": "2023-10-05",
    "ADY": 1060,
    "AGE": 64,
    "AGEGR1": "<65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0022",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 14.15,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2020-03-08",
    "ADT": "2021-05-13",
    "ADY": 432,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0022",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 10.3,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2020-03-08",
    "ADT": "2021-01-16",
    "ADY": 315,
    "AGE": 73,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0023",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 18.09,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-01-21",
    "ADT": "2022-07-26",
    "ADY": 552,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0023",
    "TRTP": "Pembrolizumab + Chemo",
    "TRTPN": 1,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 18.33,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-01-21",
    "ADT": "2022-08-02",
    "ADY": 559,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 1,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0024",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "PFS",
    "PARAM": "Progression-Free Survival",
    "AVAL": 6.34,
    "CNSR": 0,
    "EVNTDESC": "DISEASE PROGRESSION",
    "STARTDT": "2021-05-27",
    "ADT": "2021-12-06",
    "ADY": 194,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  },
  {
    "STUDYID": "KN868",
    "USUBJID": "KN868-0033-0024",
    "TRTP": "Placebo + Chemo",
    "TRTPN": 2,
    "PARAMCD": "OS",
    "PARAM": "Overall Survival",
    "AVAL": 8.1,
    "CNSR": 0,
    "EVNTDESC": "DEATH",
    "STARTDT": "2021-05-27",
    "ADT": "2022-01-29",
    "ADY": 248,
    "AGE": 65,
    "AGEGR1": ">=65",
    "SEX": false,
    "MMRSTAT": "pMMR",
    "ECOGBL": 0,
    "SAFFL": "Y",
    "ITTFL": "Y",
    "EFFFL": "Y",
    "ANL01FL": "Y"
  }
]
